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ABSTRACT 
The role of C. elegans NHR-49 in regulating global lipid homeostasis 
Pranali Path are 
Chair of the Supervisory Committee: 
Member, Susan Biggins 
Division of Basic Sciences, FHCRC 
Mammalian nuclear receptors broadly influence metabolic fitness and serve as 
popular targets for developing drugs to treat cardiovascular disease, obesity and diabetes. 
However, the molecular mechanisms and regulatory pathways that govern lipid 
metabolism, one of the primary energy sources in physiological settings, remain poorly 
understood. I chose the model organism C elegans to elucidate how nuclear receptors 
and their regulatory partners maintain global metabolic homeostasis and coordinate 
multiple signals from different tissues under different contexts to modulate the 
appropriate transcriptional programs. I set out to explore the impact of the C elegans 
lipid sensing nuclear receptor NHR-49 on global animal metabolism and physiology. 
Genome-wide gene expression studies revealed that NHR-49 broadly regulates target 
genes that fall into several physiological categories including energy balance, lipid 
binding, lipid degradation, sphingolipid breakdown, lipid remodeling, yolk 
synthesis/transfer and mitochondrial biogenesis. Worms lacking nhr-49 function display 
a host of phenotypes that very closely mirror its gene expression profile. I identified 
NHR-49 co-factors that influence NHR-49 gene regulation and demonstrated that each 
receptor accounts for a specific subset of NHR-49 targets. Furthermore, I used deletion 
mutants of these individual co-factors to delineate their specific contribution to distinct 
phenotypes of nhr-49-/- animals. This work has identified genes and pathways that were 
previously not known to be regulated by NHR-49. In addition, ultrastructural analysis 
revealed that NHR-49 and its partner proteins participate in the orchestration of the influx 
and efflux of global energy stores into and from different tissues. And, finally, I 
discovered a previously uncharacterized role for NHR-49 in influencing mitochondrial 
physiology. Taken together, my findings in C. elegans not only provide novel insights 
into how nuclear receptor transcriptional networks coordinate to regulate global energy 
metabolism but also reveal the breadth of their influence on different aspects of animal 
physiology. 
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CHAPTERl 
INTRODUCTION: NUCLEAR RECEPTOR REGULATION OF LIPID 
METABOLISM 
Lipid metabolism is central to energy homeostasis. Typically fat is broken down and 
can undergo several potential fates. Fatty acids from the diet can be broken down to 
generate energy via mitochondrial fatty acid ~-oxidation. In addition to providing 
sufficient levels of ATP, fatty acids are essential components of cellular membranes 
(phospholipids), long-term energy storage reserves (triglycerides) and even function in 
signaling pathways (glycolipids) (figure 1.1) (Wymann and Schneiter 2008). 
Misregulation of any of these processes can lead to inappropriate levels of fatty acids 
leading to a range of metabolic diseases including obesity, diabetes and cardiovascular 
disease. The regulatory mechanisms that mediate this very important balance are a class 
of molecules called nuclear receptors. In this work, we use the model system, C. elegans 
to expand our understanding of how nuclear receptor networks regulate metabolic 
pathways to modulate lipid homeostasis and influence animal physiology. 
Role of Mammalian Nuclear receptors in physiology 
Nuclear receptors are ligand-regulated transcription factors designed to sense 
environmental signals and respond by coordinating diverse physiological programs. They 
are regulated by small lipophilic ligands that include dietary signals and metabolic 
intermediates. Upon ligand binding, nuclear receptors undergo a confonnational change 
that switches the regulatory status of the receptor, reprogramming gene expression in 
target tissues. Nuclear receptors thus exert their effects by directing global changes in 
gene expression that act to maintain metabolic homeostasis by governing the 
transcription of genes involved in lipid metabolism, storage, transport, and elimination 
(Chawla, Repa et al. 2001). 
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Mammalian lipid sensing nuclear receptors play critical roles in metabolic health 
by regulating the homeostasis of dietary and endogenous fats, sterols and sugars. The 
PP AR nuclear receptors are global modulators of fat management controlling fat storage, 
expenditure, distribution and transport (Desvergne and Wahli 1999). Other lipid sensing 
nuclear receptors include LXR which governs cholesterol metabolism, transport and 
storage, and FXR which facilitates transport, metabolism and detoxification of bile acids 
and phospholipids (Peet, Janowski et al. 1998; Parks, Blanchard et al. 1999) . Finally, 
HNF-4a is important for lipid and glucose homeostasis (Stoffel and Duncan 1997). 
Tremendous progress has been made over the last several years to elucidate the 
role of nuclear receptors in animal biology. Due to their important roles in regulating fat 
storage and expenditure in protecting against lipid induced toxicity, lipid sensing nuclear 
receptors are aggressively targeted for the treatment of conditions associated with the 
metabolic syndrome, including diabetes, atherosclerosis and obesity. Their important 
physiological functions and potential as pharmacologic targets makes lipid sensing 
nuclear receptors an important avenue for disease intervention. In fact, agonists and 
antagonists for mammalian lipid sensing nuclear receptors have been shown to have 
significant health benefits for the treatment of metabolic disease. Current research is 
aimed at defining roles for these receptors in normal development and metabolism as 
well as better understanding how nuclear receptor dysfunction contributes to diabetes, 
cancer, cardiovascular disease, obesity, and neuronal disorders (Sonoda, Pei et al. 2008). 
C. elegans as a model to understand nuclear receptor biology 
Although studies in mammalian systems have provided insights into the 
molecular mechanisms by which nuclear receptors regulate transcription of target genes, 
open questions that still remain include the physiological purpose and effects of the 
extensive set of target genes, as well as the sub-specific impacts of co-factors. Their 
widespread effect on gene expression and physiology makes it imperative to 
comprehensively understand nuclear receptor mechanisms in order to develop targeted 
therapies with minimal side effects. The nematode C. elegans is a great model system to 
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address these shortcomings and is a simple but powerful tool to help characterize the fat 
regulatory networks and their physiological effects in vivo. These microscopic worms are 
fast growing and easy to maintain. Their total development time from egg to adult takes 
about three days. Since their genome has been sequenced, it has been shown that many 
important biological processes like lipid metabolism and fat regulatory pathways are 
conserved between worms and mammals (Porte, Baskin et al. 2005). In addition, the C. 
elegans knockout consortium makes genetic manipulability and making transgenic 
animals relatively fast and easy (Consortium 1998). 
Discovery of C. elegans NHR-49 as a regulator of lipid metabolism 
During the evolution of nematodes, the HNF4 family underwent a significant 
expansion resulting in 284 family members in C. elegans, compared to 48 in humans and 
21 in flies. Fifteen nuclear receptors have clear homologs in other species, and include 
relatives of the mammalian HNF4, Vitamin D receptor, COUP-TF, SFl, ROR, PNR, 
GCNF, TLX as well as the Drosophila DHR3, DHR38, E7S, E78, DHR78, and DHR96. 
The other 269 nuclear receptors arose from an ancestral HNF4 (Robinson-Rechavi et al., 
2005). We found that one of these nuclear receptors, NHR-49 is an important regulator of 
fatty acid metabolism. The regulatory targets and physiological effects of NHR-49 are 
strikingly similar to those of the mammalian lipid sensing nuclear receptors, HNF4-a and 
PPARa. Even though NHR-49 has a strong sequence similarity to the mammalian HNF4-
a, the overall biological effects of nhr-49 on metabolism, fat storage, and life span are 
remarkably similar to those of the mammalian PPARs (Van Gilst, Hadjivassiliou et al. 
2005). Perhaps most striking is the finding that nhr-49 and the PPARs, particularly 
PPARa and PPAR8, positively influence similar genes in multiple metabolic processes, 
including fatty acid ~-oxidation, fatty acid desaturation, and fatty acid binding/transport 
(Desvergne and Wahli 1999) (Wang, Lee et al. 2003). Moreover, knockout of PPARa or 
PPAR8 can lead to high-fat phenotypes (Wang, Lee et al. 2003) (Costet P, 2008) that are 
similar to those observed in nhr-49-/- animals demonstrating the common physiological 
effects of these receptors on fat storage. These findings suggest that studying the C. 
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elegans NHR-49 will provide insights into how and why nuclear receptors modulate fat 
expenditure, fat composition and fat distribution. 
Description of Dissertation 
The overarching goal of my project was to better understand how nuclear 
receptors coordinate signals from diverse sources and locations under different 
environmental conditions to modulate the relevant set of target genes and pathways 
needed to maintain lipid homeostasis. All organisms must balance energy input and 
output in order to live. We predicted that disruption of overall nuclear receptor activity 
via deletions of ligand binding or co-factor interactions would not only disrupt lipid 
homeostasis but would also reveal specific groups of target genes and associated 
phenotypes. 
The second chapter describes a complete characterization ofNHR-49's 
transcriptional regulatory network. Gene expression data not only confirmed the 
previously known target genes, but also revealed additional target genes including 
sphingolipid breakdown and lipid remodeling genes. We also identified three other 
nuclear receptors NHR-66, NHR-80 and NHR-13 that partner with NHR-49 to regulate 
distinct subsets of its target genes and as a result contribute to specific aspects of NHR -49 
phenotypes. In characterizing NHR-49's transcriptional network, we showed that the 
control of distinct NHR-49 regulatory modules is based on NHR-49's association with 
distinct interacting partners. These findings regarding NHR-49's binding partners and 
their physiological activities also provided considerable insights into the mammalian lipid 
sensing nuclear receptors, HNF-4a and PPARa. Despite species diversification, nuclear 
receptors act similarly across taxa to play fundamental roles in detecting intrinsic and 
environmental signals, and subsequently in coordinating transcriptional cascades that 
direct reproduction, development, metabolism, and homeostasis (Magner and Antebi 
2008). In addition to understanding the transcriptional network and target genes that 
underlie the physiology controlled by NHR-49, this work revealed several common 
themes and divergent functions in the context ofNHR-49's evolutionarily conserved 
mammalian homologs. 
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Chapter three describes the role of NHR -49 and its partner proteins in regulating 
energy stores and the resultant impact on reproduction. In particular, we used electron 
microscopy to show that NHR-49 and its partners contribute to the movement of lipid and 
distribution of glycogen between different organs of the worm and this co-ordination has 
effects on downstream outputs, like reproduction. One of the limitations in the 
mammalian receptor field is the missing link between transcriptional studies and 
physiological models. This work bridges that gap and shows for the first time that the role 
of nuclear receptors extends well beyond the transcriptional activation and repression of 
genes, and that they are in fact important mediators of energy transfer and delivery within 
cells. One of the implications of this work is that nuclear receptors can potentially act as 
sensors of supply and demand of energy and are in fact capable of modulating the output 
based on the energy input. 
In the fourth chapter, we describe a previously uncharacterized role for NHR-49 
in the regulation of mitochondrial physiology. Ultrastructural analysis revealed that 
animals lacking nhr-49 function have abnormal mitochondrial morphology. We used 
deletion mutants of NHR-49 co-factors to show that NHR-49 mediated control of 
mitochondrial shape and number could be attributed to impaired expression of genes in 
the fatty acid desaturase and sphingolipid breakdown pathways. This work demonstrates 
the involvement of very specific genes in the nuclear receptor mediated control of 
mitochondrial shape and number, paving the way for a better understanding of the 
transcriptional regulation of mitochondrial biogenesis. 
Taken together, our work studying the C. elegans NHR-49 contributes new 
knowledge to the field by providing novel insights into how nuclear receptor 
transcriptional networks coordinate with each other to regulate global energy metabolism, 
as well as uncovering the range of nuclear receptor influence on various aspects of animal 
physiology. 
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Fig. 1.1 Improper lipid homeostasis is associated with metabolic diseases. 
Imbalances in any of these processes have been shown to result in a host of 
diseases . 
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CHAPTER 2 
COORDINATE REGULATION OF LIPID METABOLISM BY A NOVEL 
NUCLEAR RECEPTOR PARTNERSHIP 
Abstract 
Global gene expression profiling confirmed that the C. elegans lipid sensing 
nuclear receptor NHR~49 coordinately influences several genes in multiple fat 
metabolism pathways, through both activation and repression. In addition to confirming 
that NHR-49 is important in modulating pathways that control fat expenditure and fatty 
acid saturation, the analysis also revealed that NHR-49 is essential for repressing the 
expression of genes predicted to participate in sphingolipid processing and lipid 
remodeling. Here we report the identification and validation of the different NHR-49 co-
factors that interact with NHR-49 to selectively modulate distinct aspects of lipid 
metabolism. Notably, we found that knockout of nhr-66 specifically abrogated NHR-49 
repression of sphingolipid and lipid remodeling targets. In contrast, deletion of nhr-66 did 
not impact NHR-49's activation of beta-oxidation and desaturase genes. Our findings 
thus support a model whereby NHR-49 collaborates with NHR-66 to regulate a system of 
genes involved in modulating the glycosphingolipid and phospholipid composition. In 
addition, we found that knockout of nhr-80 and nhr-13 affected the expression of NHR-
49 regulated fatty acid destaurase genes, but had no impact on any of its other gene 
targets. Thus, NHR-49 partners with NHR-80 and NHR-13 to regulate the ratio of 
saturated and unsaturated fat in lipid membranes. Therefore, in characterizing NHR-49's 
transcriptional network, we found that the control of distinct NHR-49 regulatory modules 
is based on NHR-49's association with distinct interacting partners. Using deletion 
mutants, we then parsed out the influence of each of the different lipid pathways on worm 
physiology. Consistent with NHR-66's repression ofNHR-49 regulated sphingolipid 
metabolism genes, biochemical analysis revealed a significantly altered sphingolipid 
profile in both nhr-49-/- and nhr-66-/- animals. Whereas, NHR-80 and NHR-13's 
modulation ofNHR-49 regulated fatty acid desaturase genes contributed towards the 
shortened lifespan phenotype of nhr-49-/- animals. Our findings regarding NHR-49's 
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binding partners and their physiological activities provide considerable insights into the 
mammalian lipid sensing nuclear receptors, HNF -4a and PPARa. 
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Introduction 
As a result of our modern day lifestyle and diet, we face a significant threat from 
a host of chronic diseases including obesity, diabetes and atherosclerosis. These 
metabolic disorders have been consistently linked to the imbalance between energy 
consumption and output. Proper energy homeostasis is thus criticaL Growing evidence 
suggests that faulty regulation of fat metabolism promotes metabolic diseases. The 
control of fat metabolism is often mediated by nuclear receptors. Nuclear receptors are 
ligand regulated transcription factors that playa central role in the cell's ability to sense, 
transduce and respond to lipophilic signals by modulating the appropriate target genes 
(Chawla, Repa et al. 2001) (Evans, Barish et al. 2004). 
Nuclear receptors typically exhibit highly conserved modular domains including 
the zinc-finger DNA binding domain (DBD) and a ligand binding domain (LBD). On 
binding to a ligand, nuclear receptors mediate transcription through their ability to 
recognize specific sequences within promoter/enhancer regions of their target genes. 
Ligand binding affects their activity by inducing structural changes within the LBD, 
which then alters the receptor's affinity to different co-factor proteins that comprise of 
co-regulators and binding partner(s). Co-regulators include both co-activators and co-
repressors, and are critical in mediating transcriptional responses. Alteration in receptor 
affinity can thus lead to a change in the transcriptional response i.e., it can result in 
replacing co-repressors with co-activators to promote transcription of target genes, or in 
recruiting other nuclear receptors to form homo- or heterodimers to activate or repress a 
specific set of target genes (Glass and Rosenfeld 2000). Thus binding of distinct co-
factors eventually determines how nuclear receptors influence different gene networks. 
The Hepatocyte Nuclear Factor 4- alpha (HNF-4a), an example of one such lipid 
sensing nuclear receptor in mammals, is mainly expressed in liver, pancreas, kidneys and 
small intestine (Miquerol, Lopez et al. 1994). It orchestrates the regulation of a diverse 
range of target genes and is especially important in the control of genes involved in 
glucose and fatty acid homeostasis (Stoffel and Duncan 1997). Consistent with its role in 
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metabolism, mutations in HNF-4o. are associated with both maturity onset diabetes of the 
young (MODY) and type II diabetes (Yamagata, Furuta et aL 1996). It is not clear how 
HJ'l'F4 protects against diabetes; but it has been reported that mutations in HNF-4o. can 
lead to early death of pancreatic beta-cells resulting in dysfunction and a subsequent 
decrease in insulin production (Rhodes 2005; Gupta, Gao et al. 2007). In addition, knock-
out of HNF -40. in adult mice livers leads to increased hepatocyte accumulation of lipid 
and also misregulation of several genes involved in glucose and lipid metabolism 
(Hayhurst, Lee et al. 2001). 
Recent data on the HNF4 receptors suggest that this nuclear receptor is highly 
conserved across species. Mammals have two paralogs of this receptor, HNF4o. and 
HNF4y. In C. elegans, however, the HNF4 family underwent a massive expansion during 
evolution resulting in 269 HNF4-like receptors (Sluder and Maina 2001; Bertrand, Brunet 
et al. 2004). Of these 269 family members, only one HNF4-like receptor NHR-49 shares 
not only a significant structural homology but also displays similar gene expression 
patterns as the mammalian HNF-4o.. These nuclear receptors share a conserved ligand 
binding pocket, co-activator interface and DNA recognition sequences. They target 
similar metabolic pathways, like fatty acid ~-oxidation, lipid transport and 
gluconeogenesis, and also respond to a similar physiological cue, like fasting (Dhe-
Paganon, Duda et al. 2002; Van Gilst, Hadjivassiliou et al. 2005). Thus, NHR-49 is the 
worm homolog of mammalian HNF-4o.. Also, consistent with mouse liver-specific HNF-
40. knockout mutants, nhr-49-1- mutants accumulate increased body fat. These animals 
also undergo premature death reminiscent of the early death observed in HNF-4o.-
deletion-induced pancreatic beta-cells (Van Gilst, Hadjivassiliou et al. 2005). 
An outstanding question that remains is the significance of having so many C. 
elegans HNF4-like receptors. One possibility is that gene expansion could have allowed 
for worms to distribute the different HNF4-regulated functions and "outsource" them to 
several individual nuclear receptors. Another possibility is that they simply evolved 
additional novel functions. In this study, we set out to distinguish between these 
possibilities by elucidating the NHR -49 regulated gene network and characterizing its 
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target genes. We also sought to understand the impact of this transcriptional regulation on 
worm physiology. We have identified NHR-49 co-factors and uncovered additional roles 
for NHR-49 in the regulation of lipid metabolism. Our findings support a model whereby 
NHR-49 heterodimerizes with other nuclear receptors and co-regulators to mediate the 
activation or repression of genes involved in distinct aspects of lipid metabolism. Using 
knockout strains, we were also able to selectively modulate the effects of individual 
NHR-49 co-factors to further investigate the shortened lifespan phenotype of nhr-49-/-
animals. 
Results 
Full-genome microarray analysis of NHR-49 
Initial studies in our lab revealed that NHR-49 promoted two distinct aspects of 
lipid metabolism, namely fatty acid de saturation and fatty acid beta-oxidation. However, 
the complete list ofNHR-49's regulatory targets was still not known. To address this, we 
performed transcriptional profiling ofNHR-49 to identify all the genes that it regulated. 
We used full-genome C. elegans oligonucleotide microalTays to compare a nhr-49 
(nr2041) deletion strain with N2 wildtype worms. We thus identified a total of 140 genes 
as regulated more than 2-fold in the nhr-49 deletion strain. The Wormbase annotation and 
fold change of the top activated and repressed genes are listed in table 2.1 and 2.2. The 
strongest activated genes include the previously known targets ofNHR-49 namely the 
fatty acid beta-oxidation and fatty acid desaturase genes. Of the strongest repressed 
genes, these experiments uncovered new NHR-49 targets that include genes involved in 
sphingolipid breakdown, lipid remodeling and xenobiotic detoxification. 
Identification of additional factors that participate in regulation ofNHR-49 target 
genes 
Nuclear receptors never act alone and often interact with other nuclear receptors 
to form heterodimers, or act with other co-factors to promote or inhibit gene expression. 
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We hypothesized that NHR-49 differentially regulates its distinct target genes by 
interacting with specific transcriptional co-factors. Yeast-two hybrid experiments 
(performed in theY amamoto lab) that used NHR-49 LBD as the bait protein identified 
numerous proteins that directly bind to NHR-49 (table 2.3), including numerous other 
nuclear receptors. We then systematically evaluated each of these by using their deletion 
mutants and performing qRT-PCR to investigate if they affected NHR-49 gene 
regulation. The qRT-PCR panel included the topmost NHR-49 activated and repressed 
genes (see primer pairs, table 2.4 and 2.5). In doing this, we found 2 potential co-factors 
that controlled different NHR-49 target genes: NHR-66 and NHR-13. In addition to these 
three candidates, NHR-80 had previously been shown to regulate the fatty acid desaturase 
genes (Watts and Browse 2002). Since these genes overlapped with NHR-49's gene 
targets, we chose to include NHR-80 in our analysis. 
NHR-49 physically interacts with NHR-66, NHR-80 and NHR-13 
We next wanted to assess ifNHR-49 directly binds to these candidate interacting 
nuclear receptors. We performed in vitro GST pull-down assays to verify NHR-49's 
interaction with full length NHR-66, NHR-80 and NHR-13 proteins. Since earlier work 
(yeast-two-hybrid) had shown that NHR-49 was capable of interacting with itself and 
therefore forming homodimers, we used NHR-49 as a positive control. We performed 
pull-down assays with in vitro translated 35S-methionine labeled NHR-49, NHR-66, 
NHR-80 and NHR-13 and purified glutathione-S-transferase (GST)-tagged NHR-49. 
GST-NHR-49 successfully formed a homodimer by pulling radiolabeled NHR-49 down 
and was also able to form heterodimers with NHR-66, NHR-80 and NHR-13. In other 
words, binding reactions consistently demonstrated the interaction of labeled NHR-49, 
NHR-66, NHR-80 and NHR-13 with GST-NHR-49 but not with the GST alone control 
(figure 2.1). 
NHR-66 represses NHR-49-regulated sphingolipid and lipid remodeling genes 
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Once we established that NHR-49 directly binds to NHR-66, NHR-80 and NHR-
13, we next wanted to characterize their common NHR-49 dependent target genes. The 
deletion ofnhr-66 (ok940) resulted in ~he upregulation of most of NHR-49's repressed 
genes. We found that NHR-66 is required for the repression of27 out of30 ofNHR-49's 
repressed genes. In both nhr-49 and nhr-66 mutants, the expression of sphingolipid and 
lipid remodeling genes are strongly induced. These genes include the sphingolipid 
breakdown enzymes like acid ceramidase, glycosyl hydrolase, sphingosine-phosphate 
lyase and lipid remodeling genes like phospholipases, TAG lipases and 0-
acyltransferases. In contrast, nhr-66 mutants did not show any change in the expression 
profile of nhr-49 activated genes, like those involved in beta-oxidation and de saturation 
(figures 2.2A and 2.2B). These results strongly imply that NHR-49 acts with NHR-66 to 
repress the transcription of sphingolipid and lipid remodeling genes. 
To address ifNHR-66 was regulating only NHR-49 dependent genes or ifNHR-
66 regulated additional genes of its own, we performed a microarray analysis on nhr-66-
/- mutants. The list of the strongest NHR-66 upregulated and downregulated genes is 
presented in table 2.6 and 2.7, respectively. Thus our analyses suggested that NHR-66 is 
not only a transcriptional partner required for NHR-49 gene repression, but may also be 
part of other transcriptional networks regulating additional genes independent of those 
controlled by NHR-49. 
NHR-80 and NHR-13 activates NHR-49-regulated fatty acid desaturase genes 
On the other hand, we found that the nhr-80 (tmiOIl) and nhr-13 (Ve 1656) 
deletion mutants exhibit a decrease in expression of fatty acid desaturase genes. In other 
words, NHR-80 and NHR-13 are important for the activation ofNHR-49 regulated fatty 
acid desaturase genes:fat-7,fat-5 andfat-6. These are members of the ~9 fatty acid 
desaturases and are key enzymes in fatty acid metabolism. Their function is to introduce 
a double bond in saturated fatty acid chains to generate monounsaturated fatty acids 
(MUF As). Production of MUF As by these desaturases is the first step of the desaturation 
pathway and these MUFAs are incorporated into lipids such as phospholipids and 
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triglycerides where they play essential roles in membrane fluidity and energy storage 
(Ntambi 1995). The nhr-80-/- and nhr-13-/- animals had no impact on NHR-49, s beta-
oxidation genes or its sphingolipid metabolism and remodeling genes (figures 2.2A and 
2.2B). These results suggest that NHR-49 associates with NHR-80 and NHR-13 to 
regulate the ratio of saturated and unsaturated fat in lipid membranes. Again, our NHR-
80 data is in accordance with what was previously shown by the Watts lab (Watts and 
Browse 2002). 
We also performed a full genome-wide microarray analysis on nhr-80-/- to 
determine ifNHR-80 had regulatory targets independent ofNHR-49. The list of the 
strongest NHR-80 upregulated and downregulated genes is presented in table 2.8 and 2.9, 
respectively. Thus our analyses showed that in addition to interacting with NHR-49, 
NHR-80 could potentially act with other binding partners to regulate other sets of genes. 
NHR-49's regulation of desaturases is contributing to lifespan 
The binding assay and gene expression data together support a model whereby the 
control of distinct NHR-49 regulatory modules is based on NHR-49's association with 
distinct interacting partner proteins. In other words, the regulatory targets ofNHR-49 are 
separable based on what binding partner NHR-49 interacts with. Using deletion mutants 
of each interacting NHR-49 partner, we wanted to determine the individual effects of the 
different co-factors on the phenotype of nhr-49-/- mutants. We chose to investigate the 
reduced lifespan phenotype of nhr-49-/- animals. We performed lifespan assays on nhr-
66-/- mutants to examine the effect ofNHR-49's repressed genes on lifespan. These 
mutants had no effect on lifespan, and we thus ruled out the possibility that the NHR-49-
regulated sphingolipid and lipid remodeling genes played a role in the reduced lifespan 
phenotype. Next, we performed lifespan assays on nhr-80-/- and nhr-13-/- mutants. At 
20 DC, these mutants were significantly shorter-lived with a lifespan of 13.19+/-0.3 8 days 
and 14.17+/-0.4 days respectively, compared to that of 17.35+/-0.34 days observed in 
wildtype worms. In fact, the nhr-80-/-; nhr-13-/- double mutant had a lifespan of 12 days 
comparable to that of the nhr-49-/- mutant that has a lifespan of 9.52+/-0.23 days. These 
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results suggest that the reduced expression of fatty acid desaturases observed in the nhr-
80-/- and nhr-13-/- mutants might be contributing to the shortened lifespan of nhr-49-/-
animals (figures 2.3A and 2.3B and table 2.11). 
These observations are in accordance with previous published work 
demonstrating that shortened lifespan phenotype results from lowered expression of the 
fat-7 SCD (Van Gilst, Hadjivassiliou et al. 2005). In addition, both nhr-49-/- and worms 
grown onfat-7 RNAi have a concomitant increase in the levels of saturated fat. More 
specifically, the reduction in desaturase levels results in the alteration of the ratio between 
stearic acid and oleic acid (C18:0IC18:1n9) to almost 4 times higher (about 3.74+1-0.33 
in nhr-49-/- animals) than that seen in wildtype animals. We thus evaluated the saturated 
fat levels of the deletion mutants. We used GC-mass spec to measure the abundance of 
individual lipid species and then compared the ratio ofC18:0 to CI8:l to that ofnhr-49-/-
mutants. We found that like the nhr-49-/- mutants, the nhr-80-/-;nhr-13-/- double mutants 
also had higher value ofC18:0ICl8:1n9 (2.99+1-0.22) relative to wildtype (0.98+1-0.06) 
(figure 2AA and table 2.12). In fact, we see a strong inverse correlation (r"'2=0.86) 
between the level of saturated fat and the duration of mean worm lifespan (figure 2Ab). 
This observation supports the notion that the accumulation of excess saturated fat as a 
result of reduced fatty acid desaturase expression is playing a role in the early death 
phenotype of the nhr-49-/- mutant. These results also suggest that NHR-49's interaction 
with NHR-80 and NHR-13 is contributing to the shortened lifespan phenotype that is 
observed in nhr-49-/- mutants. 
nhr-49-1- and nhr-66-1- animals have an altered sphingoJipid composition 
The gene expression data also predicted that deletion of nhr-49 and nhr-66 would 
lead to the increased breakdown of glycolipids, as well as their metabolic intermediates. 
To assess the contribution ofNHR-66 to the phenotype of nhr-49-/- animals, we 
separated total lipid from N2 (wildtype), nhr-49-/- and nhr-66 worms into their 
glycolipid species and fractionated them using thin layer chromatography (TLC). As 
expected, we found that deletion of nhr-49 and nhr-66 both affect the composition of 
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simple glycolipids. In particular, we see a decreased abundance of lactosyl~ceramide in 
mutant worms as compared to wildtype N2 worms. In contrast, the ratio of abundance of 
galactosyl ceramide is increased in mutant worms as compared to N2s. This is consistent 
with the qRT-PCR data where both nhr-49-/- and nhr-66-/- mutants were shown to have 
increased expression of glycosyl hydrolase that breaks down lactosyl ceramide and 
increased expression of galactosyl ceramide transferase that degrades ceramide into 
galactosyl ceramide (figure 2.5). This data suggests that NHR-49 collaborates with 
NHR-66 to regulate a system of genes involved in modulating the glycosphingolipid 
membrane composition. These observations also confirm that NHR-49's interaction with 
NHR-66 is contributing to this altered sphingolipid composition phenotype in nhr-49-/-
mutants. 
Discussion 
In addition to NHR-49's affects on genes involved in fatty acid beta-oxidation and 
fatty acid de saturation, our present study has revealed a previously uncharacterized group 
ofNHR-49 targets, namely genes involved in the repression of sphingolipid processing 
and lipid remodeling. We also identified several NHR-49 interacting partner receptors, 
NHR-66, NHR-80 and NHR-13 that discern between and modulate only selective NHR-
49 depcndent pathways. Furthermore, each of these regulatory modules ofNHR-49 is 
separable and contributes to a specific phenotype ofthe worm. In characterizing NHR-
49's transcriptional network and studying the resulting influence on physiology, our 
findings will better inform us of the common evolutionary history of all HNF -4 receptors 
across species and their conserved metabolic pathways and physiological functions. 
Ongoing dispute over the number and identity ofHNF-4a's target genes has yet to 
be worked out. Several studies have reported varying number of genes regulated by HNF-
4a, employing a range of experimental approaches, including transient transfection of 
HNF-4a into a hepatoma cell line, a rat insulinoma cell line, and a human kidney cell line 
(Naiki, Nagaki et aL 2002; Lucas, Gdgo et aL 2005). Notably, Odom et al performed 
chIP on chip to identify promoters occupied by HNF -4a in the human liver and pancreas 
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and revealed an extremely high number ofHNF-4a -targeted promoters; 1575 potential 
HNF4 target genes (Odom, Zizlsperger et aI. 2004). In contrast, a study by Gupta et al 
analyzing at gene expression regulation in pancreatic cells of an HNF -4a conditional 
knockout model, identified only 133 genes as HNF-4a regulated (Gupta, Gao et al. 2007). 
This disparity in the number ofHNF-4a target genes is still not resolved. We addressed 
this issue in our study by using gene expression profiling to comprehensively identify all 
of the C. elegans HNF-4a homolog, NHR-49's target genes. These experiments revealed 
a novel role for NHR-49 in the regulation of genes involved in membrane lipid 
metabolism, particularly glycosphingolipid processing. Interestingly, a connection has 
not yet been reported for the role ofHNF-4a in regulating sphingolipid metabolism in 
genome-wide expression studies in mammals. 
In addition to the controversy over the target genes, the different co-factors of 
mammalian HNF -4a responsible for influencing distinct aspects of gene expression have 
not been fully identified. Since the core functions ofHNF-4 have been conserved from 
yeast to drosophila to mammals, it is reasonable to expect that HNF-4 co-factors in C. 
elegans would behave in a functionally similar manner to those in mammals. 
Furthermore, since the co-activator interface that is important in mediating the interaction 
of co-factors to nuclear receptors is perfectly conserved between HNF-4a and NHR-49, 
our findings are of particular relevance to mammalian systems. We have thus taken 
advantage of C. elegans genetics to successfully identify NHR-49's multiple partners and 
confirm their interaction with NHR-49. Notably, we found that knockout of nhr-66 
affected only a subset ofNHR-49 targets: sphingolipid and lipid remodeling target genes 
and knockout of nhr-80 and nhr-13 affected the expression ofNHR -49-regulated fatty 
acid desaturases. In addition, in vitro binding assays further confirmed that NHR-49 can 
physically interact with NHR-66, NHR-80 and NHR-13. We thus suggest a model 
whereby NHR-49 and NHR-66 heterodimerize to regulate a system of genes that mediate 
the breakdown of glycolipids and remodeling of lipid membranes. And, NHR-49 together 
with NHR-80 or NHR-13 sense and regulate the balance between saturated and 
unsaturated fat (figure 2.6). 
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Besides the three NHR-49 binding partners, the two hybrid assay had also 
identified the C. elegans Mediator subunit, MDT-I5. MDT-I5 has previously been 
shown to act as a transcriptional co-activator ofNHR-49 necessary in the regulation of 
NHR-49's activated genes including the fatty acid beta-oxidation and desaturase genes 
(Taubert, Van Gilst et al. 2006). Even though co-activators typically promote gene 
expression, their activities can be somewhat nuanced. For instance, under certain 
promoter contexts, co-activators can repress gene expression in a gene-specific manner. 
We found that MDT-I 5 indeed regulated a subset ofNHR-49's repressed genes (data not 
shown). It cannot be ruled out, however that these NHR-49 repressed genes are 
upregulated as a means of compensating for impaired NHR-49 activated genes, like beta-
oxidation or desaturases. However, it is important to note that (1) NHR-66 regulates these 
genes in the absence of impaired beta-oxidation and desaturation (2) RNAi of beta-
oxidation genes and RNAi ofJat-7 did not result in upregulation ofNHR-49's repressed 
genes. Thus MDT -15 can potentially function to repress NHR-49 gene expression in a 
manner that we do not yet understand. 
Another interesting finding of this study is the complexity of the NHR-49 
regulatory network. Our microarray data suggests that in addition to the common target 
genes jointly regulated by NHR-49INHR-66 and NHR-49INHR-80, NHR-66 and NHR-
80 regulate additional genes independent of that ofNHR-49. Essentially, both NHR-66 
and NHR-80 have their own network of players distinct from those involved in NHR-49 
gene transcription. 
In addition, our lifespan analysis revealed that NHR-80 and NHR-13 are the 
regulatory modules contributing to the early death of nhr-49-/- deletion mutants. i.e. 
NHR-49's interaction with NHR-80 and NHR-13 modulating the levels of saturated and 
unsaturated fat playa part in the shortened lifespan phenotype of nhr-49-/- deletion 
mutants. Furthermore, there is a significant correlation between the ratio of C18:0 to 
C18:1n9 and reduced mean lifespan leading us to speculate that NHR-49 maybe 
protecting against early death by preventing an excessive accumulation of saturated fat. 
This is especially interesting given that the mechanism of how mammalian HNF-4a 
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protects against diabetes is still not known. Several studies have used both in vitro and 
animal models to show that pancreatic beta cells are highly susceptible to saturated fat-
induced apoptosis or Iipotoxicity (Shimabukuro, Higa et al. 1998; Unger and Zhou 2001). 
Moreover, additional studies provide further evidence that overexpressing SCD protects 
against this lipotoxicity (Listenberger, Han et al. 2003; Peter, Weigert et al. 2008). These 
observations raise the possibility that the mammalian HNF-4a might be employing a 
similar mechanism as the C. elegans NHR-49 to protect against premature death. 
Although this hypothesis needs to be further tested, it seems very reasonable given NHR-
49's structural homology to HNF4 and its physiological activities. 
Despite NHR-49's strong structural homology to HNF-4a, functionally NHR-49 
more closely resembles the mammalian nuclear receptor PPARa. Like NHR-49, PPARa 
activates fasting-response genes involved in gluconeogenesis and also regulates fatty acid 
beta-oxidation and lipid transport. Similar observations were made in drosophila where 
dHNF4 was reported to behave functionally analogous to that of mammalian PPAR-a, 
regulating beta-oxidation and playing a role in the starvation response (Palanker, 
Tennessen et al. 2009). Consistent with their role in metabolism and fasting, PPAR-a 
mutant mice have also been shown to display a defective response to starvation and have 
enlarged lipid droplets in their liver (Hayhurst, Lee et al. 2001). In fact, even S . cerevisiae 
shares common heterodimeric partners, Oafl/Pip2 that are strikingly similar in structure 
and function to PPAR-a and its binding partner RXR (Phelps, Gburcik et al. 2006). Thus, 
in comparing HNF-4 and HNF-4-like nuclear receptors across species (table 2.13) from 
yeast to mammals, a common theme that emerges is the conservation of its role in lipid 
metabolism pathways all throughout evolution. It is tempting to speCUlate that the 
ancestral role ofHNF-4 was adopted by PPAR-a to primarily include mobilization of 
stored energy during nutrient deprivation and the regulation of beta-oxidation, while the 
other functions ofHNF-4 were either retained or outsourced to additional nuclear 
receptors. 
By the same reasoning, we speculate that when the HNF -4 gene underwent a 
massive expansion in C. eiegans, the precursor HNF-4 receptor allocated its various 
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functions to different nuclear receptors. Paralogs of the HNF-4 receptor in nematodes 
could then have been selected for divergent functions that included sphingolipid 
metabolism and xenobiotic metabolism. In other words,just like PPARlRXR adopted 
specific Hl\TF-4 roles in mammals, NHR-49 heterodimerized with different binding 
partners to adopt individual tasks that encompassed the numerous functions of the 
precursor nematode HNF-4. This is particularly intriguing given the striking absence of 
any C. elegans orthologs ofRXR-like molecules that in mammals/fruit flies/yeast 
heterodimerize with a range of interacting proteins. It might be possible that sometime in 
evolution C. elegans lost an RXR ortholog but since NHR-49 behaves as a promiscuous 
partner forming heterodimers with other nuclear receptors, it may have assumed an RXR-
like function. i.e., NHR-49 could serve as an ancestral binding partner reminiscent of the 
mammalian RXR. C. elegan<; thus represents a class of animals that switched from solely 
using HNF-4 receptors to regulate lipid metabolism to those that began to employ 
different heterodimeric partners to regulate distinct metabolic pathways. 
The role of mammalian Hl\TF-4a however is not limited to energy metabolism; 
HNF-4a is also involved in several physiological processes such as hepatocyte 
development and differentiation, blood coagUlation and immune function. A possible 
explanation for this could be that the mammalian HNF -4 receptors evolved novel 
functions to accommodate these additional roles, as organisms became more complex. 
Besides the conservation of common metabolic pathways, HNF-4a also shares 
conserved co-regulatory modules, across species. For example, the C. elegans co-
activator MDT-IS and the mammalian co-activator PGC-la collaborate with NHR-49 
and PPAR-a respectively in their response to fasting (Taubert, Van Gilst et al. 2006). 
In closing, our study has identified distinct binding partners that modulate specific 
pathways ofNHR-49 activity. Given the conservation ofHNF-4 structure, function and 
regulatory modules across species, it is very plausible that mammalian HNF-4a utilizes 
similar mechanisms as that of C. elegans NHR-49, thus informing us of ways to 
selectively modulate its activity. Exploring these possibilities can assist in 
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pharmacological efforts to manipulate mammalian HNF-4a for specific desired outcomes 
without any detrimental side-effects. 
Materials and methods 
Nematode strains and growth conditions 
C. elegans strains N2-Bristol (wildtype), nhr-49 (nr2041), nhr-66 (ok940), nhr-80 
(tmlOll) and nhr-13 (VC16S6) were used for all experiments. Worms were maintained 
by standard techniques at 20°C. Single-worm PCR was used to determine the genotype of 
worms during crossing to generate nhr-80-1-; nhr-13-1- double-mutant lines. For mRNA 
and GC/MS analysis, worm embryos were allowed to hatch on unseeded nematode 
growth media (NGM)-lite plates overnight at 20°C. The next day, synchronized L1 
larvae were plated onto NGM-lite plates seeded with Escherichia coli strain OPSO. 
Worms were grown to early L4s at 20°C, harvested, washed three times with M9 and 
flash-frozen in liquid N2. 
Preparation of total nematode mRt~A 
C. elegans strains N2-Bristol (wildt ype) , nhr-49 (nr2041), nhr-66 (ok940), nhr-80 
(tmlOll) and nhr-13 (VC1656) were grown at 20°C on high-growth plates seeded with 
OP50 bacteria. Gravid adults from 10 IO-cm plates were bleached, and embryos were 
dispersed onto IS-cm nematode growth media (NGM)-lite plates seeded with OPSO. 
Worms at L4 stage were harvested, washed twice with M9, and frozen in liquid nitrogen. 
For RNA preparation, worms were thawed at 65°C for 10 min, and RNA was isolated 
using the Tri-Reagent Kit (Molecular Research Center, Cincinnati, Ohio, United States). 
Isolated total RNA was subjected to DNAase treatment and further purification using 
RNAeasy (Qiagen, Valencia, California). 
22 
qRT-PCR and microarray analysis 
cDNA was prepared from 5 j..lg of total RNA in a 100-j..l1 reaction using the 
Protoscript cDNA preparation kit (New England Biolabs, Beverly, Massachusetts, United 
States). Primer pairs were diluted into 96-well cell culture plates at a concentration of 3 
j..lM. Next, 30-j..l1 PCR reactions were prepared in 96-well plates. Each PCR reaction was 
carried out with TagDNA Polymerase (Invitrogen, Carlsbad, California, United States) 
and consisted of the following reaction mixture: 0.3 j..lM primers, 1/500th of the cDNA 
reaction (corresponds to cDNA derived from 10 ng of total RNA), 125 j..lM dNTPs, 1.5 
mM MgCh, and IX reaction buffer (20 mM Tris pH 8,4, 50 mM KCI). 0.15 j..ll (0.75 
units) of TagDNA Polymerase was used for each reaction. Formation of double-stranded 
DNA product was monitored using SYBR-Green (Molecular Probes, Eugene, Oregon, 
United States). Data were collected using RNA from at least three independent C. elegans 
growths. To determine the relationship between mRNA abundance and PCR cycle 
number, all primer sets were calibrated using serial dilutions of cDNA preparations. gRT-
PCR primers were designed using Primer3 software. 
For microarray analysis, RNA was then labeled with Cy3 or Cy5 and hybridized 
to Washington University manufactured C. elegans microarrays. Data was obtained from 
three independent biological replicates and analyzed using GenePix Pro 6.0 software. 
Ratios were calculated using background corrected, and normalized data (global mean). 
gPCR was performed using a BioRad iCycler (MyiQ Single color). 
Fatty acid analysis 
Fatty acids were isolated from 1 0,000 L4 animals grown on a single 15-cm NGM-
Lite plate. Total lipids were extracted and converted to fatty acid methyl esters (FAMEs) 
as described (Watts and Browse). After incubation at 80°C for 1 hour the samples were 
cooled and the FAMEs were extracted by adding water and hexane. FAMEs were 
analyzed for fatty acid composition by gas chromatography/mass spectrometry (GCIMS) 
(Agilent 5975GC, 6920MS). Peaks were assigned using fatty acid standards. For 
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sphingolipid analysis, the lipids were further separated using a pre-equilibrated column 
and the different lipid fractions, including the glycolipids were eluted. The samples from 
the different mutant strains were then run on a TLC plate. 
Plasmids 
The PCR products of the full length NHR-49, NHR-66, NHR-80 and NHR-13 
were inserted into the expression vector pcs-2 that was generously given to us by Dr.B 
Eisenmann (FHCRC). For bacterial expression, GST-NHR-49 was constructed by 
inserting BamHI-NHR-49 coding sequence-EcoRI into PGEX-2Tvector. All the clones 
were confirmed by sequencing analysis. 
GST -pull down assays 
GST-fused NHR-49 (GST-NHR-49) was expressed in the Escherichia coli BL21 
(DE3) strain and purified using glutathione-Sepharose 4B beads. 35S-methionine-Iabeled 
proteins were prepared by in vitro translation using the TNT-coupled transcription! 
translation system with conditions as described by the manufacturer (Promega: Madison, 
WI). In vitro protein-protein interaction assays were carried out. 
Lifespan assays 
Approximately 30-40 L 1 worms were transferred to 6-cm plates seeded with 
L4440 RNAi bacteria and life-span assays were carried out at 20°C as described 
previously. The L4 stage was counted as day O. Adults were transferred to new plates 
daily until progeny production had ceased. Animals were considered dead when they no 
longer responded to a gentle tap with a worm pick. Life span curves and statistical data 
including p-values from Log-rank (Mantel-Cox) test were generated using GraphPad 
Prism version 5 software (GraphPad Software, San Diego, California, USA). 
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Fig. 2.1 
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Fig. 2.1. NHR-49 physically interacts with NHR-49, NHR-
66, NHR-80 and NHR-13 in vitro. Pull-down assays 
showing in vitro translated 35S-methionine labeled NHR-49, 
NHR-66, NHR-80 and NHR-13 binding purified GST-
NHR-49 fusion protein versus purified GST -alone control. 
The protein mixtures of 35S-methionine-Iabeled NHRs were 
incubated with glutathione-sepharose 4B beads and 
analyzed by SDS-P AGE (4-12%). The input represents 
0.1 % of the labeled proteins used for the pull down assays. 
The experiments were repeated three times. 
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Fig. 2.3 
10 20 
day of adulthood 
N 
Z j; 
! 
.s::. 
c 
, 
.,. 
o 
~ 
.s::. 
c 
-e- N2 
..... nhr-49-/-
-S- nhr-66-/-
.. nhr-80-/-
...... nhr-13-1-
...- 80-1-;13-1-
30 
Figure 2.3. Double mutants nhr-80-1-; nhr-J 3 have a reduced lifespan 
similar to that of nhr-49-1- animals. 
A. The percentage of animals remaining alive is plotted against animal 
age. Adult lifespan survival curves ofWT (empty circles), nhr-49 (2041) 
(empty triangles), nhr-66 ( ok940) (empty squares), nhr-80 (tm 1 011) 
(filled circles), nhr-J 3 (vc1656) (filled squares) and double mutant nhr-
80-1-; nhr-J 3-1-(filled triangles) animals. The curves shown represent 
pooled data from at least 4 independent experiments. 
B. The bar graph represents the combined mean (+I-SEM) adult lifespan 
from at least 4 independent experiments. 
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Fig. 2.4 
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Figure 2.4. Higher levels of saturated fat in nhr-80-/-;nhr-13-/- and 
nhr-49-/- animals correlate to shortened life spans. 
A. Relative abundance of individual fatty acid species expressed as 
percentage of total measured fatty acid. Fatty acids were isolated 
and quantified by GC/MS from WI (white bars), nhr-49-/- (grey 
bars), nhr-66-/- (black bars), nhr-80-/- (horizontal stripes), nhr-13-
/- (vertical stripes) and nhr-80-/-; nhr-13-/- (dotted bars) animals. 
Error bars represent standard error. Data represent the mean of at 
least 4 independent experiments. 
B. Correlation between the ratio ofC18:0 to C18:1n9 and mean 
lifespan. 
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Figure 2.5. Altered sphingolipid profile in nhr-49-/- and nhr-66-/ - animals 
compared to wildtype controls. 
Quantification of different sphingolipid species obtained from wildtype, nhr-
49-/- and nhr-66-/- animals using Thin Layer Chromatography (TLC). 
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Figure 2.6. Proposed model ofNHR-49 transcriptional network. 
NHR-49 (in blue) interacts with NHR-66 (in pink) and is necessary for the 
repression of genes involved in sphingolipid processing and lipid 
remodeling. NHR-49 (in blue) also binds to NHR-80 (in green) and NHR-
13 (in purple) to regulate the activation of the desaturase genes. 
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Table 2.1. List of genes upregulated in nhr-49-/- compared to wildtype N2 
animals. The data is a result of analysis of three independent mRNA 
isolations and microarray hybridizations. 
Table 2.1 
Genepairs name seQuence description fold change 
B034B.2 small integral membrane lysosome 17.B 
B0222.4 tag-3B, sphingosine phosphate lyase 12.B 
F45E4.1 arf-1, ADP ribosylation factor 7.07 
ROBH2.9 nhr-269 6.B 
Y65B4BR.1 phospholipase 4.5 
Y37H2A.11 microtubule associated lipoprotein 4.49 
C29F3.5 sugar binding lectin 4.39 
ZK21B.5 secreted surface protein 4.2 
W03Bl.6 integral membrane O-acyltransferase 4.17 
ZK617.2 TAG lipase 4.12 
F27E5.1 acid ceramidase 4.11 
E02H9.5 glycosyl hydrolase 4.07 
T10B9.1 cyp13A4 3.9 
C36C5.14 3.9 
C29F3.2 sonic hedgehog 3.95 
T24C4,4 3.B8 
F54F3.3 TAG lipase 3.7 
ZK218.3 secreted surface protein 3.6 
Y46C8ALA c-Iectin 3.59 
C47FS.S galactosyl transferase 3.43 
C47Al0.1 pgp-9 abc transporter 3.3 
C04G6.5 salt-stress induced peptide 3.23 
F35ES.8 gst-38 3.21 
C47F8.B nhr-81 3.16 
T19D12.4 leukocyte adhession glycoprotein 3.0 
Y67AlOA.1 integral membrane O-acyltransferase 3.0 
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Table 2.2. List of genes downregulated in nhr-49-/- compared to 
wildtype N2 animals. Values represent fold changes from average 
mRNA levels obtained from three independent biological replicates. 
Table 2.2 
Genepairs name seq uence description fold chanqe 
F28FS.2 acs-2 25.6 
Fl0D2.9 fat-7 16.2 
K12G11.3 alcohol dehydrogenase 6.S5 
C17C3.12a acdh-2 5.05 
C45811.3 dhs-18 4.63 
F18E3.7a D-aspartate oxidase 4.52 
C32Hll.12 dod-24 4.33 
F18E3.7a D-asparatate oxidase 3.94 
Y10Dl0A.9 lectin 3.89 
Y38El0A.15 3.25 
T09F5.9 c-type lectin 3.24 
F23C8A ubiquitin regulatory protein 3.23 
F18E3.7a D-aspartate oxidase 3.2 
Y7588AA mitochondrial ATP-dependent protease 2.99 
C47F8.1 F-box protein 2.95 
R09Dl.7 chitinase 2.94 
F48G7.3 nhr-83 2.93 
F45C12.1 EGF receptor-like 2.92 
C53A3.3 nitophenyl phosphatase 2.92 
R13Dl1.1 2.85 
C17C3.12b acdh-2 2.85 
Y34F4.2 2.82 
C36M.l cyp-2Sal 2.8 
F53G2.1 centriolin serine threonine kinase 2.78 
F09F3.9 cpt-S 2.78 
Fl1 AS.3 rab-2 GTPase 2.78 
R08C7.8 serine threonine phosphatase 2.75 
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Table 2.3. List of candidate proteins identified using Yeast 
two hybrid analysis using NHR-49-LBD as bait. 
1. nhr-13 
2. nhr-19 
3. nhr-22 
4. nhr-49 
5. nhr-66 
6. nhr-71 
7. nhr-76 
B. nhr-79 
9. nhr-BO 
10.nhr-l0S 
Table 2.3 
11.nhr-234 
12.nhr-243 
13.nhr-247 
14.nhr-256 
15. MDT-15 
16. efl-l 
17.lin-45 
lB. ttr-27 
19. vab-l 
20. F54AS.l1 
21. F54D1 0.7 
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Table 2.4. List of forward primers used for qRT-PCR. 
Table 2.4 
Well OlltloName Setluence s' to 3' Well OUao Name Seauence 5' to 3' 
Al 180348,2 caa toeaslcasataa.aca Fl 1f'47F8.1 "tlce".,- [GO 
11\2 rB022i:4 tiro rn>nlllorl""."r 2 IR09017 acllccaccacctoalttoa 
A3 F4SE4 1 totllatoolooacanllcn Ei F48G7.3 a.ace ..... 
A4 Riii!lm !ooo'clncccatUlo!l8CC E4 F45C12.1 ceacella tcoaaaoaaacg 
IA5 YAAR48R 1 'efn~~!r [<lU'1Ooolo<: 5 Ir.~~ A3 2 a.Ma Ie .oIiGeea.cttee 
\6 'Y37H?A,11 8nniocaMccaaaMMC 1'6 R13Dll 1 Ie, 8rlcal(;aUt,'aall( c 
AT 1"'29F35 Atnnneletttlnicaainn 1::7 1'341'4.2 toattc8cUaaaoc Ic!o c 
AS ZK21S.5 caaaGeoo a to la ttca toc E8 36M 1 aa a Iota a 110 ooaa. 10 lac 
IA9 1""038-1.6 Itcacae E9 F53G2,j ataeato aattaeantatao 
Al0 lKA112 I", aa", ene, , aaHcac(: 10 FllA5: l.aoloa!lOrll~n'n'tlnn 
11 'F27E',1 cn taceao!. MaaacUaa E11 RORer A le.coaacl'Qlcleanoaaoo 
1112 E02HQ.5 lanelettclcn "In aaalCG p K?r,.',l ""MotaM"M'" .-, 
81 Tl0B9.1 Inn lI"a"aa~allnnclion Fl Y73B6BL 11 , ctt •• calotQ(JOUotQC 
1!i:L ,'1I'r.<; 14 "n "MAnntl,"a F2 M04C94 aalcoct C 
IS3 1t.?9F3.? IInnaaat(lcltcc8Ica, , ri'~ SiiA 1,6 "2' ''''.C02 •• 'n ••• n .tne 
IB4 r?4C4,4 bi:iMtlloclooeltOI\lOa F4 T0203,1 Baaeallo aalceQcl!lll.c 
las FS4F~ CCltnaamnaloMlao IF" 4fiF5 1 iaaolooacr.r.oaIOalaaao 
B6 ZK218.3 ca aconatneteelca.ec F6 Kl0C? 3 C8clnUOloalc<lo8( aGe 
~ y 4R ~RA .4 ."n, Fi ZK550,G aaa aaalane C47F8.5 GCAOfIAooaalollltaaa a F8 Rl06.2 oaccoclattototacltcc 47A 1-01 lo!o';o; F9 T0584.3 ccaaoacc!o!ooattcloc 
B10 C()4(:lfi 5 I" sa"""I"n"lac,,""I,,C Fin F19Rlil ' ioncaaa"'n2","u.rr 
Bl1 F3r.E8,8 icc naaaaaccccatacaacc Fl1 't~Fl0.1 ( (:"IG"I(:".cl~~cCQloc 
12 'd1fRH "lIn.n' ,n F!? 09Hl1.7 ittc.llltlMcncla.lM 
Cl T19D12,4 ctcala!tltoocacaotcc 1(.; ~ K 10C3.6. 'lacGaocal 
C2 Y61A lOA 1 .H', G2 al,1 caccactoaaoanccacoc 
C3 f57B9 a cl, teae.cw, ca'lnaa, , IF,i ,,';i~2 ,alaealloa, 
C4 ZK218,1~ Ilccaatcatctccclcttoc G4 , ei.7a cnenlnclC8<lctclQQC 
IC5 ~Al11 C"a aneUna"aatlollealc" In~ ",,<.7 ,,"en,,,"' 
C6 Y73F8A8 cancltnlcaocaotcttoc IrlR NHR·23 i<"oatatlct.laOCIQ!!"o 
11"7 P7"1' Illerr G7 ROG8r-,6 Iteeattt 
08 11/)(115 aeaceola !<lAnUao.lcc IGa KI1D124 ,alolclcoe 
Ics T24El2i; Iccaael ace 09 4eG~A 10 aaoo a GO aaeac taesanoe 
1~10 CI;4E45 IcaaaanlooGioaaaUcn Ir.Hl :mll':l 9 !aoac 
ICl F4fifl11.1 aoa.tlaaaotoMooaatO 011 F40F4 ~ cto(.llctt,'lInoaoct< G 
IC12 Ic" B4,1h ftor G12 T22G~,6 I~ cfcI::;~t:::~f::aQ:gC 01 R52.6 It1::::;:~~1~i::a:l HI E04f6.5b 102 Iwn'''1' 1 1Hz fat·7 03 ZC443 5 ~i3 !tAI.s leoao. 04 K12G1U H4 fat-B GttClnla" Ir ftcooaoo 
05 4iffi 11.ii I"foctoa locaaBacl"cco H5 
= 
"lal.ooctclolatUoo Ie 
06 F1AE1,7a laconacntootlclttco H6 ~ a8uctlt'l aalocttioincQ 7 1,.. .. 1111.1? letcalc.! Inn C" tr.r.Hloc H7 55B7,4A acaacatcaaattacacaaoc 
08 YI90HIA.9 llaciooaoctiec( atalne it,s F2BD1.9 
09 Y3!lElOA1S Ic\ooaatcatccoloatco H9 iC()2Bl0.1 cloaotalootooalr.too 
'010 TIl!lF5 ~ ItO" IHiIl ihr,BD 
011 F23CS.4 caatlccoactlclcoaloa H11 nh,:Allh "r.alttcca, al'" Ie" 
012 Y7!iBRA.4 toaloo H12 nhr-GSe cleacancMcn.tnacloc 
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Table 2.5. List of reverse primers used for qRT~PCR. 
Table 2.5 
t calte! !t a a! 
Table 2.6 
Name ID logFC AveExpr P.Value function 
ZK218.5 cea2.i.48948 7.10 7.40 1.81E-09 secreted surface protein 
F56H6.5 cea2.i.03172 5.59 7.26 4.69E-09 GDP mannose dehydratase 
B0222.4 cea2.i.31956 5.27 7.86 3.21E-08 tag-38, sphingosine phosphate lyase 
F41D3.11 cea2.i.02605 4.06 6.39 0.00000714 glycosyltransferase 
Y65B4BR.1 cea2.i.06720 4.01 6.59 0.000000473 phospholipase 
ZK617.2 cea2.i.31736 3.96 9.27 2.79161E-06 tag lipase 
F56H6.1 cea2.i.03125 3.94 5.15 0.035191188 ga1actosyltransferase 
F56H6.l1 cea2.i.03134 3.77 5.13 0.035304876 integral membrane O-acyltransferase 
Y 46C8AL.4 cea2.i.30277 3.42 6.26 0.000319317 c-1ectin 
B0348.2 cea2.i.3 2048 3.28 8.58 1.49225E-06 
Y67A1OA.1 cea2.i.06753 3.18 8.33 4.17979E-08 integral membrane O-acyltransferase 
F46B3.7 cea2.i.39241 3.16 5.84 0.02183245 
T26E4.9 cea2.d.08064 3.11 6.36 0.000773916 
T26E4.1O cea2.d.08063 2.95 5.86 0.004450069 
F56H6.7 cea2.i.03190 2.90 S.62 0.005213923 
C53B4.7b cea2.d.0 1787 2.85 6.85 3.3700SE-06 bre-1 
B0554.4 cea2,i.32177 2.56 6.32 5.38644E-06 
F!IAS.5 cea2.i.36289 2.45 7.23 4.40064E-07 predicted glycosyltransferase 
Y 46C8AL.2 cea2,i.30269 2.43 7.34 1.5938E-06 c-lectin 
F57E7.1 cea2.d.29913 2.36 6.33 1.00499E-05 
T28C6.6 cea2. d.406S1 2.25 13.75 0.036004092 col-3 
K1lH12.4 cea2.i.27460 2.23 8.27 3.31344E-06 
F38H12.3 cea2.i.38647 2.22 7.39 8.30508E-07 nhr-181 
F27E5.1 cea2.i.11595 2.20 9.08 S.l0014E-06 acid ceramidase 
F11A5.8 cea2.i.36313 2.12 5.98 0.003181542 O-acyltransferase homolog 
F08F8.5 cea2.p.l58384 2.10 6.97 1.06924E-06 numr-l nuclear localized metal responsive 
F58B3.2 cea2.d.30172 2.06 9.30 8.44982E-05 Iys-S 
F41D3.l cea2.i.02594 2.0S S.64 0.00177113 nhr-82 
B0454.8 cea2.i.08369 2.02 7.42 1.70699E-05 
T20D4.7 cea2.d.39379 1.96 6.27 0.000296875 thioredoxin 
C07G3.2 cea2.i.32798 1.93 6.80 3.61822E-OS irg-1 infection responsive gene 
Y73F8A.9 cea2.d.47046 1.85 9.38 0.000237431 pqn-91 
E02H9.5 cea2.3.07963 1.80 6.10 0.000396968 klo-2 beta-glucosidase 
ZK1010.7 cea2.c.25574 1.76 11.29 0.003609609 col-97 
F13E9.8 cea2.p.90496 1.68 6.93 0.000554869 
Y73F8A.9 cea2.d.47041 1.67 8.07 0.000444577 pqn-91 
W02B12.1 cea2.p.48441 1.62 9.38 3.40121E-05 phospholipase 
YlOSCSA.4 cea2.d.41903 1.61 9.58 0.000217985 pqn-77 
Y39G 1 OAR cea2.p.20677 1.56 6.66 0.001941983 ugt-31 UDP-glucuronosyltransferase 
ZK666.7 cea2.c.15765 1.54 6.88 0.003833373 c-Iectin 
T19D12.4 cea2.p.4725! 1.52 9.64 2.12179E-05 
F45Dl1.14 cea2.d.26120 1.52 7.05 0.040389476 
Rl2E2.l4 cea2.p.158399 1.51 I1.S7 0.000272437 
T06E4.10 cea2.i.43867 1.48 5.72 0.001316791 
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Table 2.7. The top downregulated genes in nhr-66-/- animals. Genes are 
ordered by highest statistical significance of underexpression in nhr-66-/-
animals vs control N2 animals. The data represent the output of "limma" 
analysis from three independent mRNA isolations and microarray 
hybridizations. "ID" refers to the identity of individual spots on the arrays, 
"logFc" represents the log of the fold change, "A veExpr" represents the 
averaged spot intensity and "Function" refers to the predicted or actual 
function according to Worm base. 
Table 2.7 
Name ID logFC AveExpr P.Value function 
T05B4.3 cea2.c.38150 -5.92 7.28 6.044E-08 phat-4 
C49G7.3 cea2,d,17457 -3,99 6.80 0,0034499 secreted surface protein 
ZK1025,3 cca2,i.07449 -3.85 7.74 0.0001157 predicted small mol methylase 
T27E4.4 cea2.c.38832 -3.44 9.52 4.047E-06 fip-2 
C49G7.4 cea2.c.50260 -3.32 5.62 0.0009528 phat-3 
ZK1025.5 eea2.d.48138 -2.34 6.65 2. 844E-05 
C29F3.5 cea2,i.33937 -2.27 6.77 0.0002765 c-Iectin 
C27C7.4 cea2,d.14567 -2.14 6.23 0.0015523 nhr-73 
ZK1025.10 eea2.d.48121 -2.07 5,99 0.0052083 nhr-245 
T09A12.4c cea2.d.38246 -2.06 4.98 0.0200565 nhr-66 
T05B4.9 cea2.d.37120 -2.00 6.07 0.038735 secreted surface protein 
C27C7.4 cea2.d.14568 -1.85 5.87 0.000437 nhr-73 
C27C7.8 cea2,d.14571 -1.72 5.60 9.75E-05 nhr-259 
F38A3.1 cea2.p.39129 -1.61 8.44 0.0386752 col-81 
ZK1025.6 cea2.d.48143 -1.53 7.68 3.526E-05 nhr-244 
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Table 2.8. List of top upregulated genes in nhr-80-/- worms compared to 
wildtype worms. Genes are ordered by highest statistical significance of 
overexpression in nhr-80-/- animals vs control N2 animals. The data 
represent the output of "Emma" analysis from three independent mRNA 
isolations and microarray hybridizations. "ID" refers to the identity of 
individual spots on the arrays, "logFc" represents the log of the fold 
change, "A veExpr" represents the averaged spot intensity and "Function" 
refers to the predicted or actual function according to Wormbase. 
Table 2.8 
Name ID logFC AveExpr P.Value 
C26F1.9 cea2.c.34189 3,30 12,25 0.00118939 rpl-39 
K02F2.2 cea2.c.04646 2.18 13.47 0.00417723 ahcy-l 
F59D8.2 cea2.3.17694 2.11 10.12 0.00276135 vitA 
C04F6.1 cea2,d.10603 2.01 10.91 0.00102914 vit-5 
F59D8.1 cea2.d.30363 2.00 10.95 0.00135702 vit-3 
B0412.4 cea2.c.16346 1.86 13.50 0.00081612 rps-29 
M18.! cea2.p.96223 1.74 11.17 0,0114384 col-129 
C42D8.2 cea2.p.l58069 1.69 10.78 0.00265827 vit-2 
F55Bl1.2 cea2.p.93808 1.68 7.52 0.0048175 
F26FI2.1 cea2.p.l15085 1.66 8,47 0.02553253 col-140 
F41F3.4 cea2,p.116685 1.64 9.26 0.01851528 col-139 
Y62H9A.6 cea2.c.48585 1.63 7.79 0.00968345 
F54E7.2 cea2.c.19871 1.62 12,40 9.37E-05 rps-12 
KOIG5,7 cea2.c.21122 1.60 12,58 0.00049039 tbb-l 
ZC373.2 cea2.p.156987 1.54 7.93 0,00271114 
FllG11.l1 cea2,p.36165 1.50 8.85 0.00962828 
C23GlO.3 cea2.c.17471 1.49 11.63 0,02217814 rps-3 
C44B12.1 cea2.p.87992 1.49 9.02 0.00125503 
F59D8.1 cea2,dJ0360 1.46 9,22 0.02460609 vit-3 
T21G5,3 cea2.c.06057 1.46 11.11 0.00036855 glh-l 
D 1054.1 0 cea2.c.34996 1.44 9.27 0.01935949 
K07H8.6 cea2,p.95377 1.44 9.98 0.00696731 vit-6 
ZKI193.1 cea2.c.49373 1,43 9.33 0.03410419 col-19 
Y37D8A.19 cea2.c.23704 1.42 8.07 0.01382848 
F02A9.3 cea2.d.01994 1,42 14.28 0.03509986 far-2 
W02D9.7 cea2.p.l8814 1,40 6,84 0.02354035 
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Table 2.9 
Table 2.9 lists the top downregulated genes in nhr-80-/- animals. Genes are 
ordered by highest statistical significance of underexpression in nhr-80-/-
animals vs control N2 animals. The data represent the output of "limma" 
analysis from three independent mRNA isolations and micro array 
hybridizations. "ID" refers to the identity of individual spots on the arrays, 
"logFc" represents the log of the fold change, "A veExpr" represents the 
averaged spot intensity and "Function" refers to the predicted or actual 
function according to W ormbase. 
Name ID logFC AveExpr P.Value 
FlODl.9 cea2.c.35201 -5.55 8.18 5. llE-08 fat-7 
ZC395.5 cea2.i.22724 -2.59 8.64 0.0006134 
ZK666.7 cea2.c.15765 -2.37 6.64 0.0107795 c-1ec 
ZK666.6 cea2. i.18053 -2.23 8.61 7.33E-05 c-1ec 
W06Dl2.3 cea2.c.39182 -2.17 8.62 1.58E-06 fat-5 
C45G7.3 cea2.d.16969 -2.16 6.74 0.0008412 ilys-3 
C53A3.2 cea2.i .35082 -2.05 7.99 0.0004818 p-nitrophenyl phosphatase 
F38Ell.1 cea2.i.25955 -1.81 8.35 6.65E-06 hsp-12.3 
T09F5.9 cea2.p.124403 -1.75 11.13 3.49E-06 c-lec 
K09Hl1.7 cea2.d.33151 -1.73 10.59 7.59E-05 p-nitrophenyl phosphatase 
C50F7.5 cea2.p.88996 -1.49 6.79 0.0269632 
F49Ell.10 cea2.c.28925 -1.48 10.19 0,0198191 scl-2 
F15E11.1 cea2.d.20845 -1.46 12.26 0.0009359 
K12Gll.3 cea2.c.37571 -1.41 12.44 0.0133202 sodh-l 
Y 119D3B.9 cea2.i.21452 -1.38 6.88 0.0146278 fbxa-21 
F53A9,8 cea2.c.45618 -1.38 10.60 0.0014786 
VZK822L.1 cea2.c.31436 -1.29 11.00 2,85E-05 fat-6 
Y34F4.2 cea2.p.75989 -1.29 5.80 0.0005652 
HlOE21.3a cea2.d.30973 -1.29 8.76 0.0011026 nhr-80 
C02A12.4 cea2.p.107596 -1.28 9.59 0.01082171ys-7 
Y51A2D.4 cea2.p.l29201 -1.26 7.27 0.0013754 hmit 
C44C1.6 cea2.c.42196 -1.23 7.45 0.0079665 
F54Bl1.11 cea2.i.54612 -1.20 9.09 9.18E-05 
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Table 2.10 
Table 2.10. Summary of gene expression data using qRT-PCR on nhr-49-/-, nhr-
66-/-, nhr-80-/- and nhr-13-/- animals with respect to wildtype controls. 
Values represent fold change +/- SEM of nhr-49-/-, nhr-66-/-, nhr-80-/- and nhr-
13-/- normalized to wildtype levels. 
Gene name Gene Overall fold change with respect to wildtype 
nhr-49·/- nhr-66-/- nhr-80-/- nhr-13-/-
acid ceramidase F27ES.1 2.29+/-0.7 2.29+/..Q.S 1+/-0.6 1.7+/..Q.S 
glycosylhydrolase E02H9.5 4+/-1.17 4+/-1.5 0.5+/-0.2 0.5+/-0.2 
sphingosine phosphate B0222.4 32+/-12.3 16+/-5.44 0.2+/-0.2 0.2+/-0.2 
lyase (SPL) 
phospholipase Y65B4BR.1 8+/-3.4 4+/-2.2 0.2+/..Q.2 0.4+/-0.4 
phosphOlipase W02B12.1 2+/-0.5 2+/-0.3 0.3+/-0.1 0.4+/-0.1 
TAG lipase ZK617.2 32+/·9.3 16+/·6.1 1+/-0.4 1.7+/-1 
O-acyltransferase Y67A10A.1 4+/-1.36 8+/-2.7 0.5+/-0.6 1+/-0.7 
fat-7 F10D2.9 128+/-53 1+/-0.3 128+/-40 73.5+/-16.9 
fat-5 W06D12.3 16+/-2.4 1+/-0.1 8+/-S.9 2.14+1-0.8 
fat-6 VZK8221.1 2+/-0.4 1+/0.3 4+/-1.2 1.5+/-0.3 
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Table 2.11 
Table 2.11. Summary of lifespan data. SEM: standard error of the mean. The 50th 
percentile is the age when the fraction of animals alive reaches 0.5. The number of 
animals is the sum of assayed worms per strain from atleast 4 independent 
experiments. 
Strain mean+/-SEM (days) 50th percentile (days) no. of animals p-value (compared to N2) 
WT 17.35+/-0.34 18 195 N/A 
nhr-49 (nr2041) 9.52+/-0.23 9.5 139 <0.0001 
nhr-66 (ok940) 17.16+/-0.41 17 96 ns (0.73) 
nhr-80 (tm1011) 13.19+/-0.38 12.5 129 <0.0001 
nhr-13 (vc1656) 14.17+/-0.4 13 135 <0.0001 
nhr-BO;nhr-13 12.29+/-0.37 11 139 <0.0001 
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Table 2.12 
Table 2.12. Lifespan and relative C 18:0 fatty acid abundance. Mean lifespan 
+/- SEM numbers represent the combined average of atleast four experiments. 
Fatty acid abundance is indicated by percent of total fatty acid measured by 
GCIMS. The percent of C 18:0 and C 18: ln9 shown is the result of four 
independent experiments. 
% of total fatty acids 
Strain mean IifeSDan C18:0 C18:1n9 ratio 
WT 16.7+/-1.5 4.98+/-0.15 5.14+/-0.22 0.98+/-0.06 
nhr-49 (nr2041) 9.5+/-0.4 8.97+/-0.62 2.46+/-0.39 3.74+/-0.33 
nhr-66 (ok940) 16.9+/-0.4 5.68+/-0.35 5.23+/-0.49 1.09+/-0.04 
nhr-80 (tm1011) 13.3+/-0.7 8.63+/-0.48 3.6+/-0.17 2.4+/-0.22 
nhr-13 (vc1656) 14.3+/-1.4 5.27+/-0.24 5.46+/-0.13 0.96+/-0.02 
nhr-80;nhr-13 12.17+/-0.8 9.74+/-0.33 3.32+/0.27 2.99+1-0.22 
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Table 2.13. Insights on evolution 
Table 2.13 
NRs Physiological role metabolic pathways structure 
Mammals homo hctcro 
HNF-4n liver differentiation, X 
nutrient transport, 
lipid metabolism, 
xenobiotic metabolism, 
glucose metabolism, 
amino acid metabolism, 
blood maintenance, 
immune function 
PPAR-nl lipid metabolism, beta-ox idation, X 
RXR cholesterol metabolism, gluconeogenesis 
glucose metabolism 
fasting response 
Drosouhila 
dHNF-4 lipid transport, beta-oxidation, X 
lipid metabolism, gluconeogenesis 
fasting response, 
gut differentiation 
C. elegans 
NI1R-49 lipid metabolism beta-oxidation, X X 
xenobiotic metabolism, fatty acid 
fasting response desaturation. 
regulation of 
sphingolipid and 
lipid remodeling 
genes, P450, 
gluconeogenesis 
NHR-66 lipid metabolism regulation of ? X 
sphingolipid and 
lipid remodeling 
genes 
NHR-80 lipid metabolism fatty acid ? X 
desaturation 
NHR·13 lipid metabolism fatty acid ? X 
desaturation 
Yeast 
OAF-lIPIP2 lipid metabolism X 
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CHAPTER 3 
ROLE OF NHR-49 IN REGULATING THE GLOBAL "LIPID ECONOMY" 
Abstract 
Mammalian nuclear receptors broadly impact metabolism. This regulation is often 
complex, involving the intersection of multiple receptors to regulate metabolic 
homeostasis in multiple organs. Therefore the ability to integrate a clear picture of each 
nuclear receptor and targets' function has not been possible. Here, capitalizing on the 
advantages of C. elegans, we have been able to illustrate the functions of NHR-49 as a 
global regulator of energy availability and reproduction. Ultrastructural analysis suggests 
that NHR-49 and its co-factors participate in the regulation of nutrient stores in the 
intestine and hypodermis. We also observe a reduced brood size and reduced mitotic 
region in the germline of nhr-49-/- animals suggesting a link between nutrient stores and 
reproduction. We also show a surprising difference between the kinetics of energy 
storage and utilization in the intestine versus the hypodermis, with the intestine being 
more responsive to short term changes in nutrient intake, whereas the hypodermis 
functions as a more stable long term lipid storage tissue. Collectively, our data suggests 
that nuclear receptors have the ability to sense global supply and demand in a "lipid 
economy". 
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Introduction 
Energy homeostasis is maintained by an extremely complex network of signaling 
pathways that operate in multiple tissues and that can mediate different aspects of energy 
balance, including nutrient uptake, storage of resources and energy expenditure. For these 
processes to occur effectively, mechanisms have evolved to sense nutrients and coordinate 
various activities between different tissues (Jones and Ashrafi 2009). Impairments in any of 
these functions is detrimental as not only does nutrient insufficiency starve important tissues, 
but the over supply of nutrients also needs to be recognized and delivered to short-term 
inventories or long-term reserves. Nutrient excess for example, contributes to metabolic 
disease, at least in part, when distribution mechanisms are no longer able to appropriately 
handle excess products. For example, pathologically high levels of lipids can overwhelm 
adiposity storage mechanisms, resulting in the overflow of lipids to cells and organs not 
readily-equipped to take on this surplus, like the heart and liver (Schaffer 2003). Therefore, in 
order to avoid catastrophic imbalances, organisms have developed various mechanisms for 
monitoring the supply and demand of various nutrient resources. 
Nuclear receptors are perhaps the most notable examples of these, responding to small 
molecule hormones or metabolites that direct a diverse set of biological mechanisms and in 
many cases, also exacerbate or mitigate associated diseases. For the metabolic syndrome, 
which involves imbalances in energy homeostasis, the lipid sensing nuclear receptors are key 
players. By binding to fatty acids ligands, these receptors can globally execute transcriptional 
programs that control all aspects of lipid metabolism, including storage, expenditure, and 
trafficking (Chawla, Repa et al. 2001; Evans, Barish et al. 2004). 
The PP AR and HNF4 are widely-studied examples of nuclear receptors that help 
control the supply and demand of various fatty acids, by sensing lipid composition in 
numerous tissues in the body (Evans, Barish et al. 2004). This is especially important as 
lipids are sourced from multiple locations, including diet, de novo synthesis, 
macromolecular breakdown, and have to be distributed to perform various tasks, such as 
fuel storage, organismal structures, and vesicular trafficking. Nuclear receptors serve not 
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only to distribute and deliver their commodities in favorable conditions, but also have to 
determine what activity is most relevant and needed, in adverse conditions. 
Nuclear receptors have been shown to run the gamut from sensing the environment 
for signals to responding to them by regulating appropriate target genes. For example, 
during times of starvation, PPARs activate genes in the beta-oxidation pathway so that 
fatty acids can be oxidized to generate energy; however, how nuclear receptors co-
ordinate the distribution and delivery of fatty acids that are needed to perform their 
different jobs, is still not known (Kersten, Seydoux et al. 1999; Leone, Weinheimer et al. 
1999). Another layer of complexity is that nuclear receptors utilize various types of co-
factors that not only help tum on and off binary responses, but also enable receptors to 
differentially regulate subsets of genes depending on specific conditions (Perissi and 
Rosenfeld 2005). 
Invertebrate models often provide excellent opportunities to bridge the gap in 
knowledge left by studies focusing on physiological phenotypes and transcriptional 
regulatory complexes. C. elegans has already been fruitful for the identification of dozens 
of novel genes and pathways involved in fat storage and metabolism, many of which 
have been confirmed in mammalian models (Ashrafi, Chang et aL 2003; Jones, Greer et 
al. 2009). For study of lipid sensing nuclear receptors, NHR-49 stands out as a good 
candidate because it has already been shown to regulate lipid metabolism gene patterns 
similar to that of PPAR and HNF4; with similar overall effects on fat storage and also a 
critical role in the fasting response, showing common environmental sensing capacity and 
downstream outputs. Thus, we set out to test the hypotheses alluded to above that lipid 
sensing nuclear receptors would be adept at precisely coordinating various inputs and 
outputs in order to regulate lipid homeostasis in response to multiple environmental 
pressures. Nuclear receptors often respond differently to the same lipophilic ligand in 
different tissues. We wanted to examine the influence ofNHR-49 on energy storage in 
different tissues of the worm. We chose to look at the intestine and hypodermis, the 
primary sites of C. elegans fat storage and metabolism to test this hypothesis and its 
predictions. 
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Results 
Overall nutritional reserves in the intestine and hypodermis are reduced in nhr-49-1-
animals 
We analyzed serial section of C. elegans using high pressure-transmission 
electron microsopy (HP-TEM) and quantitatively measured fat stores in the intestine and 
the hypodermis. We observed two distinct types of fat structures: (1) mono-layered lipid 
droplets that primarily store fat and are typically seen in the intestine and hypodermis and 
(2) multi-layered chylomicrons or yolk vesicles that transfer lipoproteins from intestine to 
oocytes. We measured the average fractional area occupied by lipid droplets in the 
intestine of adult day one nhr-49 (nr2041) animals relative to the age matched wildtype 
animals. We found that nhr-49-/- animals had a significantly reduced intestinal lipid 
droplet fractional area compared to that of wildtype animals. Another interesting 
difference was that morphologically the intestinal lipid droplets in nhr-49-/- animals had 
a "collapsed membrane" which was not observed in wildtype animals (figures 3.1A and 
3.1B). Even though, we did not observe any difference in the fractional area occupied by 
yolk droplets between nhr-49-/- and wildtype animals, we noticed that yolk droplets 
appeared morphologically different in appearance (figures 3.2A and 3.2B). 
We next compared the average size of the hypodermis in wildtype and nhr-49-/-
animals. We observed that nhr-49-/- animals had an average hypodermal area that was 
about three times smaller than that of wild type animals (figure 3.3). Just like in the 
intestine, we quantified the lipid droplets in the hypodermis of adult day one nhr-49-/-
mutants relative to the same aged wildtype animals. We observed that the hypodermal 
lipid droplets were significantly smaller in size in nhr-49-/- animals compared to 
wildtype animals (figure 3.4). In addition to lipids, another source of fuel utilized by C. 
elegans is the sugar glycogen. The nematode hypodermis is one of the primary sites of 
glycogen storage. We observed that adult day one nhr-49-/- mutants have depleted 
glycogen content in their hypodermis compared to wildtype animals (figures 3.5A and 
3.5B). 
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Taken together, these results suggested that day one nhr-49-/- animals had 
reduced nutritional reserves compared to same aged wildtype animals as measured using 
serial HP-TEM images obtained from the intestine and hypodermis. 
Co-factor partners participate in NHR-49's role in the overall nutritional reserves 
in the intestine and hypodermis 
We had shown (chapter 2) that NHR-49 physically binds to NHR-66 and NHR-80 
and they also have overlapping gene expression patterns. To test if NHR-49 partners, 
NHR-66 and NHR-80 contribute to the observed nhr-49-/- phenotypes, we examined 
adult day one nhr-66 (ok940) and nhr-80 (tmlOl1) deletion mutants. Like nhr-49-/-
animals, nhr-66-/- animals also had significantly reduced fractional area of intestinal lipid 
droplets, but had wildtype amounts of fractional area of yolk droplets (figures 3.1 Band 
3.2B). In addition, the size of the hypodermis of these mutants was comparable to 
wildtype animals (figures 3.3 and 3.4). And finally, the amount of glycogen in these 
animals was similar to that of wildtype animals (figure 3.5). Based on these observations, 
we hypothesized that NHR-66 together with NHR-49 might be playing a role in the 
regulation of the amount of intestinal lipid droplets. 
On the other hand, nhr-80-/- animals showed no significant difference in the 
fractional area of both intestinal lipid droplets and yolk droplets compared to wildtype 
animals (figures 3.1 and 3.2). Interestingly, nhr-80-/- animals had morphologically bigger 
and denser yolk droplets than wildtype yolk droplets. However, the hypodermal area of 
nhr-80-/- animals was significantly smaller than that of wildtype animals and also had 
comparatively reduced glycogen levels (figures 3.3 and 3.5). These observations seemed 
to imply that NHR-80 might be working with NHR-49 to regulate glycogen levels in the 
hypodermis. 
Our findings thus far, support the notion that NHR-49 and its co-factors 
contribute to the regulation of different nutritional reserves in different tissues. Namely, 
NHR-49 together with NHR-66 might playa role in regulating the quantity of lipid 
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droplet levels in the intestine and NHR-49 together with NHR-80 might be contributing 
to glycogen levels in the hypodermis. In fact, nhr-66-1-; nhr-80-1- animals also had 
reduced fractional area of intestinal lipid droplets (figure 3.1) and reduced hypodermal 
glycogen (figure 3.5) further strengthening this model (figure 3.6). 
Reduced fertility in nhr-49-1- animals 
In C. elegans, the energetic requirements of reproduction are very high and fats 
are processed and mobilized to the germline. Since nhr-49-1- animals have reduced 
nutritional stores, we wanted to determine if reproduction or production of germ cells 
would be affected in nhr-49-1- animals. To determine if a full complement of germ cells 
developed, the number of embryos produced was counted. We thus measured the brood 
size of nhr-49-1-, nhr-66-1-, nhr-80 -1- and nhr-66-1-;nhr-80-1- animals. By counting the 
embryos of single animals, we found that nhr-49(nr2041) mutants produced an average 
of 140 +/- 11 eggs per adult worm and nhr-80(tml0ll) animals produced an average of 
181.75 +/- 9.4 eggs per adult worm compared with an average of 291.2 +/- 8.55 eggs for 
wildtype and 256.4 +/- 6.9 for nhr-66(ok940) animals. Furthermore, nhr-66-1-;nhr-80-1-
animals that also have reduced lipid and glycogen stores also mirror the reduced brood 
size (102.1+/-10.3) observed in nhr-49-1- animals (figure 3.7). The reduced brood size 
seen in nhr-49-1- and nhr-66-1-;nhr-80-1- animals supports the idea that low reserves of 
lipid and glycogen might ultimately influence reproductive demand and result in a 
reduced number of progeny. 
Reduced mitotic region in nhr-49-1- germline 
It has been reported that in C. elegans, many more mitotic divisions are required 
for the production of a full brood than are needed for the development and growth to an 
adult. We reasoned that the one of the reasons we observe reduction in brood size might 
be a consequence of reduced mitotic divisions in the germline of nhr-49-1- animals. To 
test this, we stained extruded gonads of wildtype and nhr-49-1- animals with DAPI to 
stain the germ cell nuclei. We compared the total number of germ cells and the mitotic 
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region of wildtype and nhr-49-/- animals. The mitotic region extends from the distal tip 
of the germline tissue to the distal border of the transition zone in DAPI-stained 
germlines, transition nuclei are easily distinguished by their crescent shaped chromatin. 
Indeed, we did observe a noticeable reduction in total number of germ cells and the 
mitotic zone in day one nhr-49-/- animals compared to wildtype controls (data not 
shown) suggesting that there might be a link between energy storage, reproduction and 
germ cells. 
C. elegans lipid stores are dynamic 
C. elegan.\' energy reserves are expected to be utilized during periods of food 
deprivation. We hypothesized that if we limited the nutritional reserves of the animal for 
a period of starvation, we might see a quantitative difference in lipid droplets in the 
intestine and hypodelmis. We starved adult day one wildtype and nhr-49-/- animals for 
15 hours and then quantified their intestinal and hypodermal lipid droplets. We observed 
that about half of the intestinal lipid droplets were used up by starved wildtype animals, 
whereas almost all of the intestinal lipid droplets were used up by starved nhr-49-/-
animals, presumably because they had smaller reserves of intestinal lipid droplets to 
begin with (figure 3.8). Interestingly, we did not observe any yolk droplets in the 
intestine of the starved animals. 
We did not observe any significant difference in the fractional area of lipid 
droplets in the hypodermis compared to the non-starved controls (figure 3.9 B). This 
suggested to us that the intestine might be the primary site for short-term storage whereas 
the hypodermis could be the site for long-term storage. interestingly, starvation also 
reduced the size of the hypodermis in both wildtype and nhr-49-/- animals (figure 3.9A). 
Discussion 
Our study has shown for the first time that nuclear receptors are critical for 
maintaining proper nutrient stores in the intestine and hypodermis. Our data also suggests 
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that downstream physiological demands, like brood size are possibly affected as a result 
of the availability of accessible nutrients. We have demonstrated that wildtype levels of 
NHR-49 and its partner co-factors NHR-66 and NHR-80 are required for global energy 
stores and reproduction. We also demonstrate that the intestine and hypodermis might 
have different effects on utilization of stored lipids. 
We observed that nhr-49-1- animals have overall diminished energy stores that 
included the amount of lipid droplets in their intestine and glycogen in their hypodermis 
relative to wildtype animals. In addition, our original microarray analysis revealed that 
NHR-49 broadly targeted functional groups that included genes involved in lipid binding, 
endo and exocytotic trafficking and egg yolk transfer. Therefore, it was not surprising 
that mutants defective in NHR-49 would have defects in different facets of lipid 
distribution and trafficking. Also, even though we do not observe any difference in the 
fractional area of yolk droplets in nhr-49-1- animals compared to wildtype, we observe 
morphologically different yolk droplets in nhr-49-1- animals. Taken together, nhr-49-1-
animals not only have reduced amounts of lipid and glycogen in their intestine and 
hypodermis, they might also have oocytes defective in yolk uptake. The diminished 
supply of nutrients in the intestine, hypodermis and oocytes in nhr-49-1- animals could all 
be contributing to the observed reduced brood size. In support of the relationship between 
fat stores and fertility, Jat-6; Jat-7 animals that have reduced fat stores also have reduced 
brood size compared to wildtype (Liang, Ferguson et al. 2010). Indeed, this "cost of 
reproduction" is thought to result from mUltiple processes competing for the same 
resources. That is, as the demands for offspring production increase, there are fewer 
resources available for somatic maintenance and repair, growth and movement (Partridge, 
Gems et al. 2005). Interestingly, in Drosophila, increased nutrient availability drives an 
increase in reproductive activity (Piper, Skorupa et al. 2005). Our data fits this concept, 
whereby nhr-49-1- animals have reduced nutritional reserves and a reduced brood size. 
Since most of the resources are used up for progeny production, there might be fewer 
resources available for somatic maintenance resulting in the shortened lifespan of nhr-49-
1- (data shown in chapter 2). 
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Our work also demonstrates that NHR-49 along with its co-factors NHR-66 and 
NHR-80 regulate the total energy dynamics in C. elegans intestine and hypodermis. 
While a number of gene inactivations have been identified that alter C. elegans fat 
content, the molecular mechanisms that underlie regulation and distribution of global 
lipid stores is not known. Our data implies that deletions in NHR-49 and NHR-66 alter 
the amount of intestinal lipid droplets, whereas deletions in NHR-49 and NHR-80 reduce 
the amount of glycogen in the hypodermis. Extending this observation further, we 
speculate that NHR-49 and its partner proteins coordinate the supply of different types of 
fuel like lipid and glycogen from different tissues like intestine and hypodermis to be 
delivered to other tissues like oocytes and germline where they are utilized to meet 
different physiological demands. Additionally, our brood size data suggests that reduced 
supply of total energy stores is reflected in a smaller number of progeny. Preliminary data 
also suggests that the reduced brood size correlates with a reduced mitotic region in the 
germline. In fact, nhr-66-1-;nhr-80-1- animals which also have compromised levels of 
lipid droplets and diminished levels of glycogen have significantly reduced brood size, as 
well. These observations led us to speculate that NHR-49 and its partners not only 
regulate the coordination of fuel to different centers of supply, but further playa role in 
allocating these resources to the centers of demand. 
Since both the C. elegans NHR-49 and the mammalian PPARs regulate similar 
metabolic pathways and physiological processes, we can conjecture that our findings are 
relevant in mammalian systems. In addition to enzymatic activities of lipases, the flux of 
stored lipids through fatty acid beta-oxidation might also be dependent on nuclear 
receptor regulated coordination and delivery of lipids from multiple fat storage depots. In 
conclusion, metabolic demands are dynamic and therefore a need to constantly monitor 
global energy levels is criticaL Our work implies that nuclear receptors have the capacity 
to do exactly that, which is to sense both the supply and demand of nutrients to globally 
regulate lipid homeostasis. 
52 
Materials and methods 
Nematode strains and growth conditions 
C. elegans strains N2-Bristol (wildtype), nhr-49 (nr2041), nhr-66 (ok940), nhr-80 
(tm1011) and nhr-66-/-;nhr-80-/- were used for all experiments. Worms were maintained 
by standard techniques at 20°C. Single-worm PCR was used to determine the genotype of 
worms during crossing to generate nhr-66-/-; 80-/- double-mutant lines. For mRNA and 
GC/MS analysis, worm embryos were allowed to hatch on unseeded nematode growth 
media (NGM)-lite plates overnight at 20°C. The next day, synchronized Lllarvae were 
plated onto NGM-lite plates seeded with Escherichia coli strain OP50. Worms were 
grown to early L4s at 20°C, harvested, washed three times with M9, and flash-frozen in 
liquid nitrogen. 
High Pressure Transmission Electron microscopy 
Day one adults were placed into a 20% BSA/PBS buffer solution and prepared in 
a Leica-Impact-2 high-pressure freezer according to the following protocol: 1) 60 hours 
in 100% acetone and uranyl acetate at -90°C. 2) Temperature was ramped from -90°C to 
-25°C over the course of 32.5 hours. 3) Next, sample was incubated at -25°C for l3 
hours. 4) Next, the temperature change was brought from -25°C to 27°C in a 13 hour 
temperature ramp. Serial sections were post-stained in uranyl acetate followed by lead 
citrate. Thin cross sections were taken from resin-embedded clusters of young adults. 
Sections for adult animals were obtained from atleast 2 different animals. 
Quantification of energy stores in different organs 
Ten micron transverse sections typically spanning the length of the worm from 
the pharynx to the embryos were examined per animaL Lipid droplets, yolk and 
glycogen, intestine and hypodermis from every individual section were outlined and the 
average measurements were obtained using Image J software. Atleast two animals were 
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examined per mutant strain. Statistical data including p-values from one-tailed t-test were 
generated using GraphPad Prism Version 5 Software (GraphPad Software, San Diego, 
California, USA) 
DAPI staining 
Extmded gonads were fixed with methanol and rehydrated with phosphate-
buffered saline (PBS) at room temperature. Worms were mounted and stained with DAPI 
and Vectashield. Confocal images were taken and analyzed. 
Brood size 
Synchronized L4 animals were placed on individual plates and brood analysis was 
performed by transferring the animals to fresh plates each day and counting the laid 
embryos and hatched Lllarvae 24 hours later. Statistical data including p-values from 
two-tailed t-test were generated using GraphPad Prism Version 5 Software (GraphPad 
Software, San Diego, California, USA). 
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Fig 3.1. Quantification of lipid droplets in nhr-49-/- and its partner co-factors 
in C. elegans intestine. 
A. High pressure freezing transmission electron microscopy (HP-TEM) 
images of intestinal lipid droplets in WT and nhr-49-/- animals. 
B. The bar graph represents the mean (+I-SEM) fractional area oflipid 
droplets in the intestine of WT (white bar), nhr-49-/- (grey bar), nhr-66-/-
(black bar), nhr-80-/- (vertical stripes bar) and nhr-66-/-;nhr-80-/- (slanted bar) 
animals. Atleast two animals were examined per mutant strain. p-value 
(compared to WT) < 0.05 (significant) for nhr-49-/-, nhr-66-/- and nhr-66-/-
;nhr-80-/-. 
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Fig 3.2. Quantification of yolk droplets in nhr-49-/- and its partner co-factors in 
C. elegans intestine. 
A. High pressure freezing transmission electron microscopy (HP-TEM) images of 
yolk droplets in WT and nhr-49-/- animals. 
B. The bar graph represents the mean (+/-SEM) fractional area of yolk droplets in 
the intestine of WT (white bar), nhr-49-/- (grey bar), nhr-66-/- (black bar) and 
nhr-80-/- (vertical stripes bar) animals. Atleast two animals were examined per 
mutant strain. p-value is not significant between WT and nhr-49-/-. 
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Fig. 3.3. Quantification of the size of hypodermis in nhr-49-/- and its partner co-
factors. 
The bar graph represents the mean (+/-SEM) fractional area of hypodermis area 
in the WT (white bar), nhr-49-/- (grey bar), nhr-66-/- (black bar), nhr-80-/-
(vertical stripes bar) and nhr-66-/-;nhr-80-/- (slanted bar) animals. Atleast two 
animals were examined per mutant strain. p-value (compared to WT) < 0.005 
(significant) for nhr-49-/- and nhr-66-/-;nhr-80-/-. 
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Fig. 3.4. Quantification of hypodennallipid droplet size in nhr-49-/-
and its partner co-factors. 
The bar graph represents the mean (+/-SEM) hypodermal lipid droplet 
size in WT (white bar), nhr-49-/- (grey bar), nhr-66-/- (black bar) and 
nhr-80-/- (vertical stripes bar) animals. Atleast two animals were 
examined per mutant strain. p-value (compared to WT) < 0.05 
(significant) for nhr-49-/-. 
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Fig. 3.5. Quantification of glycogen in nhr-49-/- and its partner co-factors in 
C. elegans hypodermis. 
A. HP-TEM images of glycogen in the hypodermis of wildtype and nhr-49-/-
animals. The region of the hypodermis containing glycogen has been 
digitally colored in red to highlight the difference between wild type and nhr-
49-/- glycogen levels. 
B. The bar graph represents the mean (+I-SEM) fractional area of the 
glycogen in the hypodermis of WT (white bar), nhr-49-/- (grey bar), nhr-66-
/- (black bar), nhr-80-/- (vertical stripes bar) and nhr-66-/-;nhr-80-/- (slanted 
bar) animals. Atleast two animals were examined per mutant strain. 
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Fig. 3.6. Proposed model of NHR-49 and its co-factors in the regulation of 
different energy stores. 
NHR-49 and NHR-66 regulate the amount of intestinal lipid droplets and 
NHR-49 and NHR-80 regulate the amount of hypodermal glycogen. 
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Fig. 3.7 
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Fig 3.7. Brood size analysis of WT, nhr-49-/-, nhr-66-/- , nhr-80-/- and nhr-
66-/-;nhr-80-/- animals. 
The average number of progeny was the result of at least three independent 
experiments. p-value (compared to WT) < 0.0001 (significant) for nhr-49-/-, 
, nhr-80-/- and nhr-66-/-;nhr-80-/- and p-value (=0.0025) for nhr-66-/-
(compared to WT) 
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Fig. 3.8. Quantification of lipid droplets in 15 hour starved WT and nhr-
49-/- C. elegans intestine. 
The bar graph represents the mean (+I-SEM) fractional area of the 
intestinal lipid droplets of fed WT (white bar), starved WT (dotted white 
bar), fed nhr-49-/- (grey bar) and starved nhr-49-/- (dotted grey bar) 
animals. p-value < 0.05 (significant) compared between WT and WT 15 hr 
starved and p-value < 0.05 (significant) compared between nhr-49-/- and 
nhr-49-/- 15hr starved. 
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Fig. 3.9. Quantification of hypodermis size and fractional area of hypodermal 
lipid droplets in 15 hour starved WT and nhr-49-/- animals. 
A. The bar graph represents the mean (+/-SEM) area of the hypodermis of fed 
WT (white bar), starved WT (dotted white bars), fed nhr-49-/- (grey bar) and 
starved nhr-49-/- (dotted grey bar) animals. p-value < 0.05 (significant) 
compared between WT and WT 15 hr starved and p-value < 0.05 (significant) 
compared between nhr-49-/- and nhr-49-/- 15hr starved. 
B. The bar graph represents the mean (+/-SEM) fractional area of hypodermal 
lipid droplets of fed WT (white bar) and starved WT (grey bar) animals. p-
value not significant between WT and WT 15 hr starved. 
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CHAPTER 4 
ROLE OF NHR-49 IN MITOCHONDRIAL PHYSIOLOGY 
Abstract 
Nuclear receptor ligands that influence mitochondrial biogenesis and energy 
expenditure are popular compounds for promoting cardiovascular health, metabolic 
fitness, and overall wellbeing. The mitochondrial biogenic program involves the 
integration of several nuclear receptors that co-ordinate the expression of genes involved 
in multiple mitochondrial processes. We show that the C. elegans lipid sensing nuclear 
receptor, NHR-49 targets similar metabolic pathways to modulate mitochondrial 
biogenesis in nematodes. Like its mammalian counterparts, NHR-49 orchestrates the 
regulation of several target genes in multiple lipid metabolism pathways by partnering 
with distinct binding receptors to modulate a specific suite of genes that when knocked 
out yields corresponding sets of phenotypes. One such nhr-49 knockout phenotype that 
we observed is the significant alteration in intestinal mitochondrial number and 
morphology. This is primarily attributed to impaired expression of genes in the fatty acid 
desaturase and sphingolipid breakdown pathways. Additionally, we demonstrated that 
one of the fatty acid desaturase genes fat-7 and one of the sphingolipid breakdown genes 
acid ceramidase contribute to the aberrant nhr-49 mitochondrial phenotype. Our work 
shows the involvement of very specific genes in the nuclear receptor mediated control of 
mitochondrial number and shape, paving the way for a better understanding of the 
transcriptional regulation of mitochondrial biogenesis. 
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Introduction 
Mammalian PP AR agonists hold a lot of promise in the quest for novel 
therapeutic approaches in managing diverse metabolic and physical conditions. 
Collectively PPARs play important roles in energy homeostasis and have been implicated 
in obesity-related metabolic diseases. PPARs regulate genes involved in lipid uptake, 
storage and metabolism thereby intimately connecting them to mitochondria (Desvergne 
and Wahli 1999). Accordingly, the abundance, morphology and functional properties of 
mitochondria need to be fine tuned to meet the appropriate energy demands of specific 
cell types (Hock and Kralli 2009). However, because of PPAR' s impact on such a broad 
set of target genes, the influence of their individual genes on specific aspects of 
mitochondrial function and as a result on overall animal physiology is largely unknown. 
Therefore in spite of PPAR ligands being at the forefront of pharmacological treatments 
for the metabolic syndrome, the pleiotropic nature of their gene expression makes it 
challenging to modulate only "the desired" effects of mitochondrial properties. 
One of the co-acti vators of PP ARs is PGC-l a, which has been described as a 
nuclear factor critical for activation of genes required for mitochondrial biogenesis in cell 
culture and rodent skeletal muscle (Puigserver, Wu et al. 1998). However, even though 
no effect of PPARa or PPARa ligands on PGC-l expression have yet been reported, 
given the central and common pathways of regulation and function of PPARa and PGC-
la in liver, it has been suggested that PPARs, primarily appreciated for their effects on 
lipid metabolism, may have a wider impact on mitochondrial biogenesis and function by 
acting as transcriptional regulators of PGC-I co-activators (Hock and Kralli 2009). 
Regulatory mechanisms must provide for the induction of the broad mitochondrial gene 
set and at the same time also enable inductions of tissue and signal specific gene sets. 
The C. elegans NHR-49 is a functional homolog of PPAR-a, regulating mostly 
similar metabolic pathways and physiological processes, targeting similar sets of genes 
and displaying a similar panel of phenotypes thus providing an excellent context for 
genetic and biological studies of PPAR-a function (Van Gilst, Hadjivassiliou et al. 2005). 
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We therefore decided to take advantage of C. elegans genetics and explore the role of 
NHR-49 on mitochondrial physiology. 
Results 
NHR·49 is important for normal mitochondrial physiology 
Based on our earlier work (chapter 2), we had hypothesized that the imbalance of 
lipid saturation observed in nhr-49-/- mutants could potentially contribute to altered 
membranes in organelles like mitochondria. Furthermore, gene expression data from our 
lab revealed that in addition to genes involved in lipid metabolism, NHR-49 and its 
partners co-regulate distinct sets of genes that fall into other physiological categories 
including the control of mitochondrial morphology (unpublished data, Van Gilst lab). 
Also, since PPARs have already been established to influence mitochondria by regulating 
several lipid metabolism pathways, we decided to investigate NHR-49's role in 
mitochondrial physiology (Desvergne and Wahli 1999) (Evans, Barish et al. 2004). 
High Pressure-Transmission Electron Microscopy (HP-TEM) revealed multiple 
morphological defects in the mitochondria of one day old adult nhr-49 (nr2041) mutants 
compared to wildtype worms (figure 4.1). First, the mitochondria of the nhr-49-/-
mutants were uncharacteristically irregular in shape as seen in figures 4.1A and B. They 
appear to have a lot more turns as opposed to the more rounded wildtype mitochondria. 
Figure 4.1E shows quantitative analysis of 10 consecutive transverse sections per worm 
measuring the number of turns in the mitochondria reflecting deviation from roundness in 
nhr-49-/- mitochondria versus control wildtype animals. Second, the average size of the 
mitochondria in nhr-49-/- mutants was at least two times the size of wildtype intestinal 
mitochondria (figures 4.1A, B and F). Third, we found that the average fractional area 
occupied by mitochondria per total intestinal area in nhr-49-/- mutants was much higher 
than that in wildtype animals (figures 4.1G, H, K). Fourth, we found that the cdstae in the 
nhr-49-/- mutants appear denser and are not as distinct as those seen in wildtype (figures 
4.1A, B). Finally, we observed small vesicles associated with these abnormally shaped 
mitochondria that appeared to be budding off of them. 
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Taken together, these results suggested that day one nhr-49-/- animals had altered 
mitochondrial physiology compared to same aged wildtype animals as measured using 
serial HP-TEM images obtained from the intestine. 
Alternatively, we also labeled mitochondria using mitotracker red and used 
confocal microscopy to observe intestinal mitochondria of one day old adult wildtype and 
nhr-49 mutants. However, we did not discern any observable difference in mitochondrial 
size or number by this technique (data not shown), presumably because of the limitations 
of resolution of confocal microscopy. 
Partner co-factors contribute to NHR-49's regulation of mitochondrial number and 
morphology 
We next wanted to determine ifNHR-49 partners (chapter 2), NHR-66 and NHR-
80 were contributing to the abnormal NHR-49 mitochondrial features. So, using deletion 
mutants of each interacting NHR-49 partner, we wanted to determine the individual 
effects of the different co-factors on the phenotype of nhr-49-/- mutants. In one day old 
adult nhr-66 (ok940) mutants, the roundness of the mitochondrial membrane was 
comparable to that of wildtype animals (figure 4.1 C). However, even though the amount 
of intestinal area occupied by the mitochondria was significantly higher than wildtype 
and similar to levels seen in nhr-49-/- mutants (figures 4.11 and K), the size of the 
mitochondria (fig. 4.1F) was similar to wildtype animals suggesting that NHR-66 might 
be contributing to the number of mitochondria. 
In one day old adult nhr-80 (tml 0 11) mutants, the mitochondrial membranes 
were misshapen and not as rounded as wildtype mitochondria (figures 4.1D and E). 
However, the size and fractional area of the mitochondria in the nhr-80-/- mutants was 
comparable to that of wildtype mitochondria (figures 4.1D, F, J, K). Based on these 
observations, we hypothesized that NHR -80 is contributing to the roundness of the 
membrane, therefore regulating the morphology of the mitochondria. 
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To test this hypothesis, we examined intestinal mitochondria in one day old adult 
nhr-66-/-; nhr-80-/- double mutants and in contrast to the nhr-66-/- and nhr-80-/- single 
deletion mutants, these double mutants had highly irregular shaped mitochondria (figures 
4.2A and B), as was observed in the nhr-49-/- mutants. Thus, one possible explanation 
for the morphological abnormalities seen in nhr-49-/- mutants could be a combined effect 
of the misregulation of NHR -80 target genes (like fatty acid desaturases) and NHR -66 
target genes (like enzymes involved in sphingolipid breakdown pathway). 
Fatty acid desaturase contribute to mitochondrial morphology 
We next tested the hypothesis that reduction in fatty acid desaturase expression 
was contributing to mitochondrial shape and examined wildtype animals onfat-7 RNAi. 
Just like we predicted, these animals displayed misshapen mitochondria (figures 4.3A 
and B). This supports the idea that fatty acid desaturases might be contributing to the 
shape of the mitochondrial membrane. 
Ceramide implicated to playa role in mitochondrial number 
To determine the potential NHR-66 regulated target genes that might be 
contributing to the increase in mitochondrial number, we evaluated knockouts of the 
different NHR-66 target genes in an nhr-49-/- background to see if any of them could 
suppress this mitochondrial phenotype. Indeed, the average fractional area occupied by 
mitochondria per total intestinal area in nhr-49-/-;AC-/- double mutants was significantly 
less than that of nhr-49-/- animals and appeared to be rescued to wildtype levels (figures 
4.4A, B, C and D). Acid ceramidase breaks down ceramide to sphingosine. Thus, it is 
possible that the sphingolipid breakdown product, ceramide might be either playing a role 
in regulating mitochondrial biogenesis or promoting mitochondrial autophagy. 
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Discussion 
Taken together, our data suggest that NHR-49 plays a previously unknown role 
in regulating mitochondrial physiology. We not only demonstrate that this involvement is 
due in part to NHR-49's regulation of its sphingolipid breakdown and fatty acid 
desaturase genes but also narrow it down to very specific genes in these two pathways 
(figure 4.5). This finding has important implications in the development of better 
therapeutic treatments that can eliminate detrimental side-effects. 
Our data shows that nhr-49-/- mutants differ from wildtype animals in the size, 
number and shape of their intestinal mitochondria. It is known that NHR-49 and the 
PPARs (especially PP AR alpha and PPAR delta) influence similar genes in multiple lipid 
metabolism pathways, including fatty acid beta-oxidation and fatty acid desaturation. 
Like NHR-49, PPARs have also been implicated in regulating the density (number) of 
mitochondria. Indeed, PP AR gamma and PPAR delta have been shown to promote 
mitochondrial biogenesis in a cell-type specific manner. Treatment with PPAR gamma 
ligand pioglitazone in white adipose tissue and activation of PP AR delta in skeletal 
muscle both result in increased mitochondrial biogenesis (Tanaka, Yamamoto et al. 2003; 
Bogacka, Xie et al. 2005). However, in contrast to our data where nhr-49-/- mutants have 
mitochondria that are both uncharacteristically irregular in shape and are at least two 
times the size of wildtype mitochondria, the effects of PP ARs on these two aspects of 
mitochondrial physiology are not yet known. One possibility is that like nhr-49-/-
mutants, the different PPAR -/- mutants indeed display aberrant mitochondria but this has 
simply not been observed yet. It is also plausible that a set of genes not overlapping or 
common to NHR -49 and PPAR are contributing to the size and morphology of the 
mitochondria. In fact, our study revealed novel targets of NHR-49, mainly those 
involved in membrane lipid metabolism, particularly glycosphingolipid processing 
(chapter 2). Strikingly, a connection has not yet been reported for the role of PPARs in 
regulating sphingolipid metabolism in mammalian studies. PPARs however have been 
shown to influence mitochondrial function by mostly regulating genes encoding 
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mitochondrial fatty acid beta-oxidation enzymes and mitochondrial uncouplers 
(Puigserver, Wu et al. 1998). 
Our EM analysis revealed that NHR-66 and NHR-80 are the regulatory modules 
contributing to the aberrant mitochondrial number and shape observed in nhr-49-/-
mutants. NHR-49 interacts with NHR-66 to repress the expression of genes in the 
sphingolipid pathway whose breakdown products could be important mediators for 
maintaining the appropriate mitochondrial physiology as both nhr-49-/- and nhr-66-/-
display an increase in mitochondrial number. Interestingly, in spite of the observed 
increase in mitochondrial number, we did not see any increase in the expression of 
mitochondrial gene transcripts. Specifically, our rescue experiments with nhr-49-/-; AC-/-
double mutants demonstrate the significance of acid ceramidase in suppressing the 
altered mitochondrial density. On the other hand, NHR-49 together with NHR-80 
facilitates the conversion of saturated fatty acids to monounsaturated fatty acids, and 
consequently, both nhr-49-/- and nhr-80-/- mutants are high in saturated fat and low in 
monounsaturated fat. This skewed ratio between saturated and unsaturated fat is likely 
the reason for the altered mitochondrial membrane "roundness" seen in nhr-80-/- and 
nhr-49-/- mutants. Since monounsaturated fatty acids are substrates for phospholipids, it 
is also possible that the misshapen mitochondrial membrane could be a result of improper 
phospholipid composition. Specifically, when animals were placed onfat-7 RNAi we see 
an alteration in mitochondrial shape. Together, our results indicate that NHR-49 regulates 
mitochondrial number and morphology by regulating genes involved in sphingolipid 
breakdown and fatty acid desaturase pathways. 
Based on our findings, we propose that ceramide plays a role in mitogenesis, 
whereas the desaturase gene fat-7 impacts the mitochondrial membrane. We can further 
test this hypothesis by observing the fractional area of intestinal mitochondria in other 
players downstream of ceramide in the sphingolipid breakdown pathway, like 
sphingosine-phosphate lyase in an nhr-49 background. Although we have not yet 
determined the mechanism by which ceramide might contribute to healthy mitochondria, 
we present several possibilities. Our favored hypothesis is that ceramide might be playing 
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a role in mitochondrial biogenesis. Hickson-Bick et al confirmed that in adult 
cardiomyocytes, cerami de stimulates apoptosis, whereas in fetal cardiomyocytes 
ceramide induces mitochondrial biogenesis (Hickson-Bick, Jones et al. 2008). Another 
possibility is that if the mitochondrial phenotype observed in nhr-49-/- mutants is partly 
due to a fission-fusion defect, there is considerable evidence in the literature that 
implicates ceramides in promoting fission and thus affecting mitochondrial dynamics. 
Strikingly, another recent publication demonstrated that during starvation, 
autophagosomes originate from mitochondrial outermembranes utilizing a mitochondrial 
lipid phosphatidylethanolamine that is conjugated to autophagosome markers (Hailey, 
Rambold et al. 2010). The suppression of phenotypes that we observe in the nhr-49-/-; 
AC-/- double mutants might be a result of modulation of phosphatidylethanolamine levels 
which is downstream of ceramide in the sphingolipid breakdown pathway. 
Our finding that NHR-49 is a key regulator of mitochondrial physiology in C. 
elegans represents a considerable advance in our understanding of transcriptional 
regulation of mitochondrial biogenesis and function. As the global role of NHR-49 in the 
control of mitochondrial metabolism seems to be conserved, our findings could be 
envisaged as aiding in efforts to modulate specific target genes as opposed to a general 
manipulation of all the subsets of genes in that pathway. 
Materials and methods 
Nematode strains and growth conditions 
C. elegans strains N2-Bristol (wildtype), nhr-49 (2041), nhr-66 (ok940), nhr-80 
(tmIOll), nhr-66-/-;nhr-80-/- and nhr-49-/-;AC-/- were used for all experiments. Worms 
were maintained by standard techniques at 20DC. Single-worm PCR was used to 
determine the genotype of worms during crossing to generate nhr-66-/-; 80-/- and nhr-49-
/-;AC-/- double-mutant lines. 
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High Pressure Transmission Electron microscopy 
Day 1 adults were placed into a 20% BSAJPBS buffer solution and prepared in a 
Leica-Impact-2 high-pressure freezer according to the following protocol: 1) 60 hours in 
100% acetone and uranyl acetate at -90°C. 2) Temperature was ramped from -90oe to 
-2Soe over the course of 32.S hours. 3) Next, sample was incubated at -2Soe for 13 
hours. 4) Next, the temperature change was brought from -2Soe to 27°e in a 13 hour 
temperature ramp. Serial sections were post-stained in uranyl acetate followed by lead 
citrate. Thin cross sections were taken from resin-embedded clusters of young adults. 
Sections for adult animals were obtained from 3 different animals. 
Quantification of mitochondria 
Ten micron transverse sections typically spanning the length of the worm from 
the pharynx to the embryos were examined per animaL Mitochondria from each section 
were individually outlined and the average measurements were obtained using Image J 
software. Atleast two animals were examined per mutant strain. 
Mitotracker staining 
NOM 6cm plates were seeded with OPSO containing a final concentration of 
SOOnM mitotracker Red. Animals at L4 stage of development were placed on these plates 
in the dark at room temperature. Worms were mounted in a 2% agarose pad in M9 buffer 
containing sodium azide and then observed under a confocal microscope (Zeiss LSM SlO 
Meta). Pictures were taken by Zeiss LSM Imaging software at 40X and analyzed by 
Volocity V4.0 software. 
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Fig. 4.2 
nhr·66-/·;nhr·80·/· nhr-66-/-;nhr-8(}-/-
Fig. 4.2. HP-TEM images of nhr-66-/-; nhr-80-/- double mutants. 
Panel A and B corresponds to sections obtained from locations A and B 
highlighted in the worm schematic. Atleast three animals were examined. 
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Fig. 4.3. HP-TEM images of wildtype onfat-7 RNAi. 
Panel A and B corresponds to sections obtained from locations A and B 
highlighted in the worm schematic. 
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Fig. 4.4 
wildtype nhr-49-/- nhr-49-/-;AC-/-
D. 
WT nhr-49-1- nhr-49-1-; AC-I-
Fig. 4.4. Knockout of acid ceramidase (AC) in an nhr-49 background 
rescues the aberrant nhr-49-/- mitochondrial phenotype. 
A, B, C. HP-TEM image of N2, nhr-49-/- and nhr-49-/-, AC-/- mutants 
at the same magnification. 
D. The bar graph represents the mean (+/-SEM) cross-sectional area in 
WT (white bars), nhr-49-/- (grey bars) and nhr-49-/-, AC-/- mutants 
(dotted bars). 
Atleast two animals were examined per strain. 
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Fig. 4.5 
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Fig. 4.6. Proposed model of NHR-49's influence on mitochondria 
physiology. Our data suggests that the desaturase pathway 
contributes to the shape and the sphingolipid pathway might be 
contributing to the number of mitochondria. 
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CHAPTERS 
CONCLUSIONS AND PERSPECTIVES 
In this dissertation, I have presented a detailed characterization of the 
physiological role of NHR-49 in coordinating the mUltiple factors involved in 
maintaining the global homeostasis of lipid metabolism in C. elegans. In general, my 
work has contributed to a more complete picture of the extent to what nuclear receptors 
are capable of doing. This information is especially relevant as the technical limitations 
of mammalian studies make it difficult to address the gap in knowledge that exists 
between transcriptional regulation analyses and physiological phenotype studies. 
Compiling together the different findings that I have discovered from studying C. elegans 
NHR-49 contributes to a better understanding of the global impact of nuclear receptor 
regulated transcription on different aspects of animal physiology. Collectively, my work 
demonstrates that distinct aspects of NHR-49' s overall impact, are executed by the 
orchestration of distinct metabolic pathways that together work to support NHR-49's 
overall function. These findings can complement and contribute to studies on mammalian 
nuclear receptor physiology as using C. elegans gives us the advantage of being able to 
identify genes and pathways and dissect complicated regulatory circuits, that otherwise 
would be difficult to do. Below, I highlight the significant findings of my work and 
speculate on future research. 
Chapter 2: I demonstrated a co-ordinate regulation of lipid metabolism by a novel 
nuclear receptor partnership 
I identified genes and pathways that are globally regulated by NHR-49. Based on 
binding data and gene expression analysis, I further identified three other nuclear 
receptors that serve as co-factors for NHR-49. These co-factors regulate very spccific 
subsets of NHR-49' s comprehensive gene targets. Even though I have demonstrated that 
NHR-49 can directly bind to NHR-66, NHR-80 and NHR-13 in vitro, it has not yet been 
determined if the different target genes are direct transcriptional targets and future work 
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using either gel shift assays or chromatin immunoprecipitation can be used to address this 
question. In addition, GFP-tagged constructs of NHR-49/NHR-66 and NHR-491 NHR-
801 NHR-13 regulated genes will be useful in determining if there is overlapping tissue 
localization. 
I used the deletion mutants of the different co-factors to parse out the 
contributions of distinct target genes on specific nhr-49-/- phenotypes. Since NHR-49 
and PPARs are clearly regulating similar physiological processes and gene networks, this 
work is significant in understanding the physiological purpose and effects of the different 
target genes, especially in the context of designing therapeutic drugs with minimal side-
effects. In addition, since the comprehensive list of different co-regulators involved in the 
HNF4a and PPAR transcriptional networks is not known, identifying and studying the 
impact of C. elegans NHR-49 co-factors is an important advancement. Even though it 
can be argued that the nematode NHR-66, NHR-80 and NHR-13 do not have any clear 
mammalian orthologs, this work suggests that there likely exist other mammalian co-
factors that might function to regulate similar processes and pathways. 
Finally, one of the outstanding questions in nuclear receptor biology is the 
significance of C. elegans having such an abundant number of nuclear receptors 
compared to say Drosophila or mammals. Specifically, evolutionary studies suggest that 
the ancestral HNF4 underwent a massive gene duplication event resulting in 269 family 
members (Robinson-Rechavi et aL, 2005). One of the implications of this occurrence is 
that expansion could have allowed for worms to divide the different HNF4 functions and 
"outsource" them to different receptors. Alternatively, expansion could have allowed 
these receptors to evolve additional novel functions. This data thus provides new insights 
into the evolution of C. elegans nuclear receptor family. When I compare my findings of 
the C. elegans NHR-49 with other HNF-4-like nuclear receptors across species from 
yeast to mammals, a common theme that emerges is the conservation of its role in lipid 
metabolism pathways all throughout evolution. It can be speculated that the ancestral role 
of HNF-4 was most likely adopted by PPAR-a to primarily include mobilization of stored 
79 
energy during nutrient deprivation and the regulation of beta-oxidation, while the other 
functions of HNF-4 were either retained or outsourced to additional nuclear receptors. 
Chapter 3: We identified a novel role for NHR-49 in the regulation of total energy 
stores and the subsequent influence on reproduction 
It is not known how different transcriptional programs influence nuclear receptors 
to co-ordinate the distribution and delivery of fatty acids and sugars from and to multiple 
tissues, for the desired physiological demand under the relevant environmental condition. 
This question is technically difficult to address in mammalian systems. I used HP-TEM 
to illustrate that C. elegans NHR-49 and its co-factors are important players in the 
regulation of nutrient stores in the intestine and hypodermis. While a number of loss of 
function mutations and RNAi knockdowns have been reported that alter C. elegans lipid 
content and composition, the molecular mechanisms that regulate or affect lipid droplet 
fat stores or hypodermal glycogen stores are completely unknown. Even though further 
work is needed to identify the genes and other molecular players contributing to this 
regulation, I have demonstrated for the first time the influence of nuclear receptors in 
maintaining normal levels of lipid and glycogen stores in the intestine and hypodermis. In 
addition, I have been able to parse out the contribution of different co-factors NHR-66 
and NHR-80 to this regulation. Given that the basic aspects of lipid metabolism have 
been shown to be conserved in mammals and worms, I speculate that our findings might 
also be relevant for mammalian nuclear receptors like PP ARs. 
My data also showed a strong cOlTelation between reduced energy stores and 
compromised reproductive output. I showed that nhr-49-/- animals have a significantly 
reduced brood size and reduced mitotic region in the germline compared to wildtype 
controls. Future studies examining downstream effects on other organs can improve our 
understanding of the effect of energy stores on tissue function. Taken together, I postulate 
that NHR-49 could potentially act as a sensor for nutrient stores and accordingly adjust 
the physiological output. This hypothesis obviously needs to be tested further, but this is 
80 
a potentially exciting new framework to start thinking of the function nuclear receptors 
might be playing in coordinating "the supply and demand" of multiple types of nutrients 
to and from diverse locations in a "lipid economy" of the individual organism. 
And lastly, even though C elegans has historically been a great model for 
studying fat storage and fat metabolism, recent controversy over the current tools used to 
measure fat storage has come under considerable fire. Lipophilic dyes like Nile Red have 
been utilized to not only characterize fat storage but to also screen for novel regulators of 
fat storage; however a series of recent studies have shown that this dye primarily stains 
lysosome-related organelles which are not the primary fat storage sites in C elegans (Yen, 
Le et al. 2010) (O'Rourke, Soukas et al. 2009). My study using high-pressure electron 
microscopy has revealed that there are typically two types of lipid containing vesicles: 
mono-layered lipid droplets located in the intestine and the hypodermis and multi-layered 
vesicles yolk droplets found in the intestine. Also, Nile Red does not stain the 
hypodermis, which our study reveals to contain lipid droplets. This work suggests that 
using ultrastructural analysis might be a better alternative to evaluating fat storage by 
Nile Red as it provides a snapshot of total lipid dynamics in the whole animal. 
Chapter 4: We identified a previously unknown role for NHR-49 in mitochondrial 
physiology 
I showed that NHR-49 plays a critical role in the regulation of C elegans 
mitochondrial physiology. Ultrastructural studies revealed that nhr-49-/- animals had 
higher fractional area of intestinal mitochondria compared to controls. This is consistent 
with reports in mammalian PP ARs where they have been shown to influence the number 
of mitochondria in a tissue-specific manner (Tanaka, Yamamoto et al. 2003; Bogacka, 
Xie et al. 2005). In this study, I have primarily focused on the C elegans intestine and it 
will be interesting to see what future studies will reveal in other tissues like hypodermis 
and muscle. Additionally, nhr-49-/- animals also had misshapen intestinal mitochondria 
compared to wildtype animals. To date, there have been no studies reporting nuclear 
receptor mediated effects on mitochondria shape. It could be plausible that the different 
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PPAR -/- mutants indeed display aberrant mitochondria but they have not yet been 
observed. 
I used deletion mutants to separate out these nhr-49-/- phenotypes and identified 
the NHR-49 regulated pathways responsible for the alteration of mitochondrial shape and 
number. Specifically, my data suggested that NHR-66 together with NHR-49 regulated 
mitochondrial number and NHR-49 together with NHR-80 regulated mitochondrial shape. 
Furthermore, I identified the individual genes in these metabolic pathways that might be 
contributing to these effects. Since all the target genes of the PPAR transcriptional 
network are not completely known, it is possible that a set of genes not overlapping or 
common to NHR-49 and PPAR are contributing to the size and morphology of the 
mitochondria. In fact, this study revealed novel targets of NHR-49, mainly those 
involved in sphingolipid processing and lipid remodeling. Strikingly, a connection has 
not yet been reported for the role of PPARs in regulating sphingolipid metabolism in 
mammalian studies. PP ARs however have been shown to influence mitochondrial 
function by mostly regulating genes encoding mitochondrial fatty acid beta-oxidation 
enzymes and mitochondrial uncouplers 
Although further studies are needed to determine the molecular mechanisms that 
are responsible for the mitochondrial effects, my findings so far are still significant in the 
field especially because mammalian PPARs are known to broadly regulate an extensive 
set of target genes, but the specific influence of individual genes on distinct facets of 
mitochondrial function have not been delineated and therefore poorly understood. Since 
many of the components that are central to governing human metabolism are conserved 
in worms, our findings will definitely add to ongoing mammalian studies. 
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